学术周报 · IF≥10 或专科旗舰刊
急重症领域文献阅读汇编
2026年第46周 (2026-11-13) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| Critical care medicine | 18 | IF 7.5 |
| Annals of emergency medicine | 4 | IF 6.5 |
| European heart journal | 3 | IF 45.3 |
| British journal of anaesthesia | 2 | IF 10.3 |
| Journal of the American Chemical Society | 2 | IF 16.6 |
| Circulation | 2 | IF 41.3 |
| ACS sensors | 1 | IF 10.9 |
| American journal of respiratory and critical care medicine | 1 | IF 21.7 |
| Autophagy | 1 | IF 18.6 |
| Chemical reviews | 1 | IF 64.2 |
1脓毒症与感染性休克 (6篇)
临床研究 (5篇)
To increase the uptake of the Surviving Sepsis Campaign Hour-1 Bundle, we implemented a novel sepsis care model (National Early Warning Score [NEWS]-1 care), in which the Hour-1 Bundle is objectively triggered by a high NEWS-2 (≥ 5). We aimed to determine the feasibility of a full-scale type 1 hybrid effectiveness-implementation trial of this model. A pilot type 1 hybrid trial, comprising a stepped-wedge cluster randomized controlled trial and mixed-methods implementation evaluation with staff focus group interviews and an anonymous survey guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework. Four emergency departments in Hong Kong. Adult patients of 18 years or older with a clinical diagnosis of infection requiring hospitalization and a NEWS-2 greater than or equal to 5. Implementation of the Hour-1 Bundle when NEWS-2 was greater than or equal to 5. The primary outcome was the feasibility of a full-scale hybrid trial, evaluated based on 14 progression criteria. Preliminary clinical effectiveness and safety were assessed, alongside implementation barriers and facilitators. During the implementation phase, compliance with lactate, blood culture, and antibiotics increased significantly. All progression criteria were met, except for suboptimal overall bundle compliance (56.1%). Exploratory intention-to-treat analysis (standard care group, n = 102; NEWS-1 group, n = 98) showed no significant between-group difference in 30-day all-cause mortality (standard care group, 3.9%; NEWS-1 group, 9.2%; absolute risk difference, 5.3%; 95% CI -1.6% to 12.1%); in-hospital, 90-day all-cause, or sepsis-related mortality; need for mechanical ventilation, renal replacement therapy, intensive care, or surgery; or ventilator-free days and adverse events. Implementation evaluation identified 15 barriers and 13 facilitators. The effectiveness of NEWS-1 care remained uncertain, though adverse events were rare. A full-scale hybrid stepped-wedge trial is feasible but requires a much larger sample size. Real-world implementation barriers and facilitators should be considered in sepsis management guidelines.
中文摘要:为了提高拯救脓毒症运动第一小时Bundle的依从性,我们实施了一种新型脓毒症护理模式(National Early Warning Score [NEWS]-1护理),其中第一小时Bundle由高分NEWS-2评分(≥5)客观触发。本研究旨在评估该模式进行大规模I型混合效果与实施试验的可行性。这是一项I型混合试点试验,包含阶梯楔形集群随机对照试验以及基于Reach、Effectiveness、Adoption、Implementation和Maintenance框架的员工焦点小组访谈和无匿名调查在内的混合方法实施评估。研究地点为香港的四家急诊科。研究对象为18岁及以上成人患者,临床诊断为感染且需住院,NEWS-2评分大于或等于5。干预措施为当NEWS-2评分≥5时实施第一小时Bundle。主要结局为基于14项进展标准评估的大规模混合试验的可行性。同时评估了初步临床效果与安全性,以及实施障碍和促进因素。在实施阶段,乳酸检测、血培养及抗生素使用的依从性显著增加。除整体Bundle依从性欠佳(56.1%)外,所有进展标准均达成。探索性意向性治疗分析(标准护理组n=102;NEWS-1组n=98)显示,两组在30天全因死亡率(标准护理组3.9%;NEWS-1组9.2%;绝对风险差5.3%;95%CI -1.6%至12.1%)、院内死亡率、90天全因死亡率或脓毒症相关死亡率、机械通气需求、肾脏替代治疗需求、重症监护需求或手术需求、无呼吸机天数及不良事件方面均无显著组间差异。实施评估确定了15项障碍和13项促进因素。NEWS-1护理的效果仍不确定,但不良事件罕见。大规模混合阶梯楔形试验是可行的,但需要更大的样本量。脓毒症管理指南应考虑现实世界实施的障碍和促进因素。
Sepsis performance measures require operational definitions of "time zero", but SEP-1's heterogeneous organ dysfunction criteria may not all identify patients vulnerable to harm from antibiotic delays. To determine which SEP-1 organ dysfunctions identify patients in whom antibiotic delays are associated with increased mortality. We analyzed adults with suspected infection using electronic health record data from 145 U.S. hospitals (2018-2023). We estimated associations between antibiotic timing (1-3 vs. 0-1h and 3-6 vs. 0-3h) and in-hospital mortality for each SEP-1 organ dysfunction criterion, alone and in combination: hypotension, elevated lactate, respiratory failure, renal dysfunction, hyperbilirubinemia, thrombocytopenia, and coagulopathy. We used inverse probability weighting to adjust for baseline and time-varying confounders. Among 1,849,729 encounters with suspected infection, 624,416 had ≥1 organ dysfunction and received antibiotics within 6h of time zero. Antibiotics at 1-3 vs. 0-1h were associated with higher mortality when time zero was defined by hypotension (aRR 1.07; 95% CI, 1.03-1.10) or lactate ≥4.0mmol/L (aRR 1.10; 1.05-1.15), but not for other dysfunctions alone or in combination. Among patients without hypotension or lactate ≥4.0mmol/L, antibiotics at 3-6 vs. 0-3h were only associated with higher mortality in patients with acute respiratory failure (aRR 1.11; 1.05-1.18). Mortality associations with antibiotics beyond 1 hour were most evident when sepsis time zero was defined by hypotension or lactate ≥4.0mmol/L, and with antibiotics beyond 3 hours when defined by acute respiratory failure. These findings could inform refinements to sepsis time zero definitions to better guide antibiotic urgency and performance measurement.
中文摘要:脓毒症绩效指标需要「时间零点」的操作定义,但SEP-1的异质性器官功能障碍标准可能无法全部识别因抗生素延迟而面临伤害风险的患者。本研究旨在确定哪些SEP-1器官功能障碍标准能够识别出抗生素延迟与死亡率增加相关的患者。我们利用美国145家医院的电子健康记录数据(2018至2023年),分析了疑似感染成年患者的数据。我们估算了每种SEP-1器官功能障碍标准单独或组合使用时,抗生素给药时间(1至3小时对比0至1小时,以及3至6小时对比0至3小时)与院内死亡率之间的关联。采用逆概率加权法调整基线和时变混杂因素。在1849729次疑似感染就诊中,624416例存在至少一项器官功能障碍且在时间零点后6小时内接受抗生素治疗。当时间零点由低血压定义时,1至3小时给予抗生素与较高的死亡率相关(aRR 1.07;95% CI 1.03-1.10);当时间零点由乳酸≥4.0mmol/L定义时,同样与较高死亡率相关(aRR 1.10;95% CI 1.05-1.15),但其他单一或组合的器官功能障碍标准未显示此关联。在没有低血压或乳酸≥4.0mmol/L的患者中,仅在急性呼吸衰竭患者中,3至6小时给予抗生素与较高的死亡率相关(aRR 1.11;95% CI 1.05-1.18)。当脓毒症时间零点由低血压或乳酸≥4.0mmol/L定义时,超过1小时的抗生素延迟与死亡率增加的关联最为明显;当时间零点由急性呼吸衰竭定义时,超过3小时的延迟关联最明显。这些发现可为完善脓毒症时间零点定义提供依据,以更好地指导抗生素使用的紧迫性和绩效测量。
To evaluate the discrimination and calibration of the Sequential Organ Failure Assessment (SOFA)-2 score for ICU mortality across demographic subgroups defined by age, sex, race and ethnicity, primary language, and insurance status. Retrospective cohort study. Single academic medical center in the northeastern United States (Beth Israel Deaconess Medical Center, Boston, MA), using the Medical Information Mart for Intensive Care-IV database (version 3.1), 2008-2022, a dataset external to the SOFA-2 development cohort. Adult patients (≥ 18 yr) with at least one ICU admission. The first ICU admission of the first qualifying hospitalization per patient was analyzed. None. First-day SOFA-2 scores were calculated from the worst values recorded during the first 24 hours of ICU admission across six organ systems, with ICU mortality as the primary outcome. Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC) and calibration using intercept and slope, with subgroup differences in AUROC estimated by bootstrap resampling. Among 64,015 ICU patients (mean [sd] age, 64.6 [17.1] yr; 56.1% male; 66.1% White), overall AUROC was 0.77 (95% CI, 0.76-0.77). Discrimination declined significantly with age: AUROC, 0.85 (0.83-0.87) for ages 18-44 years vs. 0.72 (0.70-0.73) for ages 75 or older (ΔAUROC, -0.14 [95% CI, -0.16 to -0.11]), with systematic underprediction in older patients. Discrimination was significantly decreased among non-English speakers (ΔAUROC, -0.04) but did not differ across documented racial/ethnic groups. Patients with missing demographic information had markedly higher mortality than the overall cohort rate of 7.2% (14.1% for missing race/ethnicity; 23.1% for missing language). SOFA-2 demonstrated good overall performance but with clinically meaningful variation across subgroups, particularly with age and language. Patients with missing demographic data experienced markedly higher mortality. These findings argue for routine equity evaluation as a complement to traditional validation of clinical prediction tools.
中文摘要:目的:评估序贯器官衰竭评分(SOFA-2)在不同人口统计学亚组(按年龄、性别、种族和民族、主要语言及保险状况定义)中预测重症监护病房(ICU)死亡率的区分度和校准度。方法:回顾性队列研究。利用美国东北部单一学术医疗中心(波士顿贝斯以色列女执事医疗中心)的MIMIC-IV数据库(版本3.1,2008至2022年),该数据集为SOFA-2开发队列的外部数据。纳入≥18岁且至少有一次ICU入院记录的成年患者,分析每位患者首次符合条件的住院期间的首次ICU入院记录。主要结局为ICU死亡率,根据ICU入院前24小时内六个器官系统的最差值计算首日SOFA-2评分。使用受试者工作特征曲线下面积(AUROC)评估区分度,通过截距和斜率评估校准度,并采用Bootstrap重抽样估计亚组间AUROC的差异。结果:在64,015名ICU患者中(平均年龄64.6岁,男性占56.1%,白人占66.1%),总体AUROC为0.77(95%置信区间0.76-0.77)。区分度随年龄增长显著下降:18至44岁患者的AUROC为0.85(0.83-0.87),而75岁及以上患者为0.72(0.70-0.73)(ΔAUROC为-0.14,95%置信区间-0.16至-0.11),老年患者存在系统性低估风险。非英语使用者的区分度显著降低(ΔAUROC为-0.04),但在不同种族/民族群体间无显著差异。人口统计学信息缺失的患者死亡率明显高于全队列7.2%的平均水平,其中种族/民族信息缺失者死亡率为14.1%,语言信息缺失者为23.1%。结论:SOFA-2总体表现良好,但在不同亚组中存在具有临床意义的变异,尤其是年龄和语言因素。人口统计学数据缺失的患者死亡率显著更高。这些发现主张将公平性评估作为临床预测工具传统验证的补充常规进行。
Long-term outcomes after sepsis survival remain poor. No clinical laboratory tests are in use for stratifying long-term risk after sepsis, limiting the development of secondary prevention. The peripheral blood neutrophil:lymphocyte ratio (NLR) reflects innate and adaptive immune cell balance, and may reflect an immune milieu which is associated with long-term risk after sepsis. Accordingly, we evaluated the association between the NLR in the weeks after sepsis hospitalization discharge-a time when patients are routinely seen in post-ICU clinics-and long-term outcomes. Population-based cohort study. Ontario, Canada, 2010-2020. Adults discharged alive from a sepsis hospitalization. None. The exposure was the first outpatient NLR-derived from the complete blood count-measured 15-90 days after sepsis discharge. Among 37,250 survivors with available NLR, the median (interquartile range [IQR]) time-to-measurement was 34 days (22-54 d), and the median NLR was 2.7 (1.8-4.2). Within 1 year, 17,732 patients (47.6%) were rehospitalized or died (median [IQR] time-to-event, 82 d [27-185 d]). The frequency of rehospitalization or death increased across increasing NLR quartiles: 34.2%, 41.5%, 50.3%, and 64.4% (ptrend < 0.001). Compared with the lowest quartile, adjusted hazard ratios (95% CI) were 1.24 (1.18-1.29), 1.54 (1.48-1.62), and 2.25 (2.15-2.35) across higher quartiles. For most patients, NLR after sepsis returned to its patient-specific presepsis ambient level, which was itself prognostic. Among sepsis survivors, outpatient NLR measured 15-90 days after discharge is strongly associated with 1-year risk of rehospitalization or death. As a simple, widely available biomarker, the NLR may support early postsepsis risk stratification and inform development of secondary prevention strategies.
中文摘要:脓毒症幸存者的长期预后仍然较差。目前尚无临床实验室检测用于脓毒症后的长期风险分层,这限制了二级预防的发展。外周血中性粒细胞与淋巴细胞比值(NLR)反映先天性和适应性免疫细胞的平衡,可能反映与脓毒症后长期风险相关的免疫环境。因此,我们评估了脓毒症出院后数周内的NLR与长期预后之间的关联,这一时期患者通常在重症监护室后门诊常规就诊。这是一项基于人群的队列研究,数据来源于加拿大安大略省2010年至2020年。研究对象为从脓毒症住院中存活并出院的成年人。暴露因素为首次门诊NLR,源自出院后15至90天内测得的血常规。在37,250名有可用NLR数据的幸存者中,中位(四分位距[IQR])测量时间为34天(22-54天),中位NLR为2.7(1.8-4.2)。在1年内,17,732名患者(47.6%)被重新住院或死亡(中位[IQR]事件发生时间,82天[27-185天])。再住院或死亡的发生率随NLR四分位数的增加而增加:分别为34.2%、41.5%、50.3%和64.4%(ptrend < 0.001)。与最低四分位数相比,较高四分位数的调整风险比(95% CI)分别为1.24(1.18-1.29)、1.54(1.48-1.62)和2.25(2.15-2.35)。对于大多数患者而言,脓毒症后的NLR恢复到其患者特异性的脓毒症前背景水平,该水平本身具有预后价值。在脓毒症患者中,出院后15至90天测得的门诊NLR与1年内再住院或死亡的风险强烈相关。作为一种简单且广泛可用的生物标志物,NLR可能支持早期脓毒症后风险分层,并为二级预防策略的开发提供信息。
Urinary trypsin inhibitor (ulinastatin, UTI) has shown potential survival benefits in sepsis; however, conclusive clinical evidence is lacking. In patients with sepsis, does adjunctive ulinastatin, compared with placebo, reduce 28-day all-cause mortality? In this multicenter, randomized, double-blind, placebo-controlled trial, adult ICU patients with sepsis meeting Sepsis-3 criteria within 48 hours of admission were randomized (1:1) to receive intravenous UTI (400,000 IU every 8 hours) or placebo, for up to 10 days in addition to standard care. Randomization was stratified by site and septic shock. The primary endpoint was 28-day all-cause mortality. Secondary endpoints included ICU, hospital, and 90-day mortality, and ICU/hospital length of stay. Of 347 patients randomized, 340 (169 UTI, 171 placebo) received intervention and were included in the safety analysis; after 5 post-intervention withdrawals, 335 (165 UTI, 170 placebo) were included in the intention-to-treat analysis. At 28 days, death had occurred in 39 of 165 patients (23.6%) in the UTI group and in 39 of 170 patients (22.9%) in the placebo group (absolute difference, 0.7% [95% CI -8.4% to 9.7%]; P = .98; hazard ratio 1.03, 95% CI 0.66 to 1.61, P = .90). Secondary outcomes were similar in the two groups. Adverse events occurred in 56.8% (96/169) of UTI and 42.7% (73/171) of placebo patients (absolute difference 14.1%, 95% CI 3.6%-24.6%; P = 0.009). In patients with sepsis, adjunctive UTI did not reduce mortality compared with placebo. Routine use of UTI for sepsis is not supported by these findings. ClinicalTrials.gov; https://clinicaltrials.gov; NCT02647554.
中文摘要:尿胰蛋白酶抑制剂(乌司他丁,UTI)在脓毒症中显示出潜在的生存获益,但缺乏确切的临床证据。本研究旨在探讨在脓毒症患者中,与安慰剂相比,辅助使用乌司他丁是否能降低28天全因死亡率。这是一项多中心、随机、双盲、安慰剂对照试验,纳入符合Sepsis-3标准且在入院48小时内诊断为脓毒症的成人ICU患者,按1:1比例随机接受静脉注射乌司他丁(每8小时40万单位)或安慰剂,持续最长10天,同时接受标准治疗。随机化按研究中心和感染性休克状态分层。主要终点为28天全因死亡率。次要终点包括ICU死亡率、医院死亡率和90天死亡率,以及ICU和住院时长。在347名随机化的患者中,340名(169名接受乌司他丁,171名接受安慰剂)接受了干预并纳入安全性分析;在5例干预后退出后,335名(165名乌司他丁组,170名安慰剂组)纳入意向性治疗分析。28天时,乌司他丁组165名患者中有39人死亡(23.6%),安慰剂组170名患者中有39人死亡(22.9%)(绝对差异0.7%,95%置信区间-8.4%至9.7%;P=0.98;风险比1.03,95%置信区间0.66至1.61,P=0.90)。两组的次要结局相似。不良事件在乌司他丁组患者中发生率为56.8%(96/169),在安慰剂组为42.7%(73/171)(绝对差异14.1%,95%置信区间3.6%-24.6%;P=0.009)。在脓毒症患者中,与安慰剂相比,辅助使用乌司他丁并未降低死亡率。这些发现不支持常规使用乌司他丁治疗脓毒症。ClinicalTrials.gov; https://clinicaltrials.gov; NCT02647554.
基础研究 (1篇)
Sepsis constitutes a life-threatening organ dysfunction caused by a dysregulated host response to infection. SESN2 (sestrin 2), an evolutionarily conserved stress-responsive protein, is a pivotal regulator of cellular homeostasis. Here, we identified TRIM13 (tripartite motif-containing 13) as a regulator that modulated the stability of SESN2 at the post-translational level. Specifically, TRIM13 promoted K63-linked ubiquitination of SESN2 with subsequent upregulation of its functional activation. Ubiquitinated SESN2 initiated a selective macroautophagic/autophagic program that facilitated the recruitment of SQSTM1/p62 (sequestosome 1/p62) to mitochondrial surfaces. The enhanced interaction between ubiquitinated SESN2 and the mitophagy receptor FUNDC1 (FUN14 domain-containing 1) at mitochondria-associated membranes (MAMs), facilitated by this modification, potentiated the mitophagic clearance of damaged mitochondria. In addition, it inhibited the interaction between FUNDC1 and RIPK3 (receptor-interacting serine-threonine kinase 3), which in turn ameliorated dysfunction and necroptosis of dendritic cells (DCs) upon sepsis. Thus, our findings establish that TRIM13 mitigates septic responses by activating SESN2-mediated mitophagy through ubiquitination, offering new insights into potential immunomodulatory strategies for sepsis.Abbreviations: AF: AlphaFold; BECN1: beclin 1, autophagy related; CLP: cecal ligation and puncture; co-IP: co-immunoprecipitation; DAMPs: danger/damageassociated molecular patterns; DCs: dendritic cells; DEGs: differentially expressed genes; FUNDC1: FUN14 domain containing 1; IL: interleukin; LPS: lipopolysaccharide; MAMs: mitochondria-associated membranes; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MHC: major histocompatibility complex; MLKL: mixed lineage kinase domain-like; Nec-1: necrostatin-1; PBMCs: peripheral blood mononuclear cells; RIPK3: receptor-interacting serine-threonine kinase 3; SESN2: sestrin 2; SIRT1: sirtuin 1; SQSTM1/p62: sequestosome 1; TEM: transmission electron microscopy; TLR: toll-like receptor; TNF: tumor necrosis factor; TRAF6: TNF receptor-associated factor 6; TRIM13: tripartite motif-containing 13; ULK1: unc-51 like kinase 1; UPR: unfolded protein response; UPS: ubiquitinproteasome system; WT: wild-type.
中文摘要:脓毒症是由宿主对感染的失调反应引起的危及生命的器官功能障碍。SESIN2(sestrin 2)是一种进化上保守的应激反应蛋白,是细胞稳态的关键调节因子。本研究鉴定出TRIM13(tripartite motif-containing 13)为在翻译后水平调节SESIN2稳定性的调节因子。具体而言,TRIM13促进了SESIN2的K63连接泛素化,进而上调其功能活性。泛素化的SESIN2启动了选择性巨自噬/自噬程序,促进了SQSTM1/p62(sequestosome 1/p62)向线粒体表面的招募。这种修饰增强了泛素化SESIN2与位于线粒体相关膜(MAMs)上的线粒体自噬受体FUNDC1之间的相互作用,从而强化了受损线粒体的线粒体自噬清除。此外,它抑制了FUNDC1与RIPK3(receptor-interacting serine-threonine kinase 3)之间的相互作用,进而改善了脓毒症期间树突状细胞(DCs)的功能障碍和坏死性凋亡。因此,我们的研究结果确立TRIM13通过泛素化激活SESIN2介导的线粒体自噬来减轻脓毒症反应,为脓毒症的潜在免疫调节策略提供了新见解。
2ARDS与呼吸支持 (6篇)
临床研究 (5篇)
To evaluate the effect of a tele-critical care (TCC) daily audit-and-feedback intervention on spontaneous awakening trial and spontaneous breathing trial protocol compliance. Pre-post quality improvement study. Single health system composed of 14 hospitals in the Midwestern United States. A total of 8909 patients of 18 years or older receiving mechanical ventilation via endotracheal tube for more than 1 calendar day between October 01, 2022 and September 20, 2024. Daily in the early afternoon, TCC nurses reviewed mechanically ventilated patients to determine whether a spontaneous awakening trial and spontaneous breathing trial had occurred. They contacted the bedside nurse if no trial had occurred and no weaning exclusion criteria were noted during a manual chart review. The coprimary outcomes were the proportion of ventilator days during each ventilator episode with documentation of spontaneous awakening trials and spontaneous breathing trials. Linear mixed effects models were used to examine the effect of the intervention on each outcome stratified by ICU size (large ≥ 15 beds or small < 15 beds). Spontaneous awakening trial documentation improved over time throughout the entire period, but the rate of improvement increased significantly after the telemedicine intervention (preintervention slope: 0.2% increase per 30 d; 95% CI, -0.2% to 0.6% and postintervention slope: 1.4% increase per 30 d; 95% CI, 1.0% to 1.9%; p < 0.001 for intervention-time interaction). The telemedicine intervention was associated with a step increase in spontaneous breathing trial documentation in small ICUs (absolute increase, 12.8%; 95% CI, 8.7-16.9%) but not in large ICUs (absolute increase, -0.1%; 95% CI, -1.8% to 1.6%; p = 0.02 for intervention-ICU size interaction). The telemedicine intervention was associated with increased spontaneous awakening trials and spontaneous breathing trials selectively in small ICUs. Telemedicine may have promoted practice standardization in small ICUs where exposure to ventilated patients was infrequent. Local ICU characteristics may impact the effectiveness of TCC interventions.
中文摘要:目的:评估远程重症监护每日审计与反馈干预对自主唤醒试验和自主呼吸试验方案依从性的影响。设计:前后质量改进研究。背景:由美国中西部14家医院组成的单一卫生系统。对象:2022年10月1日至2024年9月20日期间,接受气管插管机械通气超过1个日历日的8909名18岁及以上患者。方法:每日下午,远程重症监护护士审查机械通气患者,确定是否进行了自主唤醒试验和自主呼吸试验。若未进行试验且手动病历审查中无撤机排除标准,则联系床旁护士。主要结局指标为每次机械通气期间记录有自主唤醒试验和自主呼吸试验的呼吸机天数比例。使用线性混合效应模型检查干预对每个结果的影响,并按重症监护室大小分层(大型≥15张床位或小型<15张床位)。结果:整个期间的自主唤醒试验记录随时间改善,但远程医疗干预后改善率显著增加(干预前斜率:每30天增加0.2%;95%置信区间,-0.2%至0.6%;干预后斜率:每30天增加1.4%;95%置信区间,1.0%至1.9%;干预时间交互作用p<0.001)。远程医疗干预与小型重症监护室中自主呼吸试验记录的阶梯式增加相关(绝对增加12.8%;95%置信区间,8.7%-16.9%),但在大型重症监护室中无此关联(绝对增加-0.1%;95%置信区间,-1.8%至1.6%;干预与重症监护室大小交互作用p=0.02)。远程医疗干预仅与小型重症监护室中自主唤醒试验和自主呼吸试验的增加相关。远程医疗可能促进了暴露于机械通气患者较少的重症监护室的实践标准化。当地重症监护室特征可能影响远程重症监护干预的有效性。
To evaluate the feasibility of conducting a randomized controlled trial investigating guanfacine for ICU delirium, including assessment of recruitment, retention, protocol adherence, and data completeness, while estimating treatment effects to inform future trial design. Single-center, randomized, double-blind, placebo-controlled pilot trial conducted from November 2020 to February 2023. Surgical and Trauma ICUs at the University of Alabama at Birmingham Hospital. One hundred critically ill adults with Confusion Assessment Method-ICU-confirmed delirium randomized 1:1 to guanfacine or placebo. Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution. Primary feasibility outcomes included protocol adherence (target ≥ 90%), retention (target ≥ 80%), recruitment rate (target ≥ 2 patients/mo), and data completeness (target ≥ 95%). Most feasibility targets were achieved: protocol adherence was 100%, retention was 100%, and data completeness was 100%. Recruitment was significantly impacted by COVID-19 pandemic disruptions, achieving 0.9 patients/wk during active recruitment periods.For clinical outcomes, in unadjusted analyses, median delirium and coma-free days were higher with guanfacine than placebo (2 [interquartile range [IQR], 0-6] vs. 1 [IQR, 0-4]; p = 0.02); however, this association was not statistically significant after adjustment for prespecified baseline covariates. ICU and hospital length of stay and duration of mechanical ventilation did not differ significantly between groups. No hemodynamic differences or safety concerns were observed. This pilot study successfully supports feasibility for a definitive trial, with excellent protocol adherence, adequate retention, and preliminary signals that warrant further evaluation. Although adjusted analyses were not statistically significant, the observed unadjusted difference in delirium and coma-free days and favorable safety profile support progression to a multicenter trial informed by these pilot estimates.
中文摘要:评估开展关于可乐定治疗ICU谵妄的随机对照试验的可行性,包括招募、保留、方案依从性和数据完整性的评估,并估算治疗效果以指导未来试验设计。本研究为2020年11月至2023年2月期间在阿拉巴马大学伯明翰医院外科和创伤ICU进行的单中心、随机、双盲、安慰剂对照试点试验。纳入100名经ICU混乱评估法确认谵妄的重症成人患者,按1:1比例随机分配至可乐定组或安慰剂组。患者每晚接受2mg可乐定或匹配安慰剂,持续最多14天,直至ICU出院或谵妄缓解。主要可行性结局包括方案依从性(目标≥90%)、保留率(目标≥80%)、招募率(目标≥2名患者/月)和数据完整性(目标≥95%)。大多数可行性目标已达成:方案依从性为100%,保留率为100%,数据完整性为100%。招募受新冠疫情干扰显著影响,活跃招募期间达到每周0.9名患者。在临床结局方面,未调整分析显示可乐定组的谵妄和昏迷-free天数中位数高于安慰剂组(2 [四分位距[IQR],0-6] vs. 1 [IQR,0-4];p=0.02);然而,在调整预设基线协变量后,这种关联无统计学意义。两组间的ICU住院时间、住院时间和机械通气持续时间差异无统计学意义。未观察到血流动力学差异或安全问题。该试点研究成功支持了确定试验的可行性,具有出色的方案依从性、充足的保留率和值得进一步评估的初步信号。尽管调整后的分析无统计学意义,但观察到的谵妄和昏迷-free天数的未调整差异以及良好的安全性特征支持推进至基于这些试点估计的多中心试验。
This trial emulation aimed to answer the question: Among patients with acute respiratory distress syndrome (ARDS) who receive lung protective ventilation with low tidal volume, is normocapnia through an increase in respiratory rate associated with lower mortality than mild hypercapnia? Target trial emulation. Hospitals of the ARDS Network and Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. Patients with ARDS enrolled in seven ARDS Network and PETAL Network randomized controlled trials. None. A target trial was emulated, assigning participants in a 1:1 ratio to normocapnia (target Paco2 35-45 mm Hg) or mild hypercapnia (target Paco2 50-55 mm Hg) for 4 days following the initiation of lung protective ventilation. The primary outcome was 90-day in-hospital mortality. Of 5367 potentially eligible subjects, 292 patients were assigned to normocapnia and 292 to mild hypercapnia. Separation in Paco2 values was preserved over the 4-day period of emulated intervention. Both groups had median pH greater than or equal to 7.33. Bicarbonate levels, driving pressure, tidal volume, and dead-space fraction did not differ clinically significantly between groups, while median respiratory rate was 33.0 breaths/min in the normocapnia vs. 28.0 breaths/min in the mild hypercapnia group (p < 0.001). Death within 90 days occurred in 84 of 292 patients (28.8%) in the normocapnia group and in 84 of 292 patients (28.8%) in the mild hypercapnia group (log-rank p = 0.842). This result persisted in subgroups such as older (≥ 65 yr) and obese (body mass index ≥ 30 kg/m2) patients. Among patients with ARDS who received lung protective ventilation, normocapnia through an increase in respiratory rate was not associated with lower mortality than mild hypercapnia. As this finding is derived from a trial emulation, it should be interpreted cautiously given the potential for significant residual bias.
中文摘要:该目标试验模拟旨在回答以下问题:在接受低潮气量肺保护性通气的急性呼吸窘迫综合征患者中,通过增加呼吸频率实现的正常碳酸血症是否比轻度高碳酸血症具有更低的死亡率。本研究采用目标试验模拟方法,数据来源于ARDS网络及急性肺损伤预防与早期治疗网络的医院。研究对象为纳入七个ARDS网络和PETAL网络随机对照试验的ARDS患者。研究模拟了一个目标试验,将参与者按1:1比例分配至正常碳酸血症组(目标PaCO2 35-45 mmHg)或轻度高碳酸血症组(目标PaCO2 50-55 mmHg),干预持续时间为肺保护性通气启动后的4天。主要结局为90天内院内死亡率。在5367名潜在符合条件的受试者中,292名患者被分配至正常碳酸血症组,292名分配至轻度高碳酸血症组。模拟干预期间PaCO2值的分离得以保持。两组的pH值中位数均大于或等于7.33。两组间的碳酸氢盐水平、驱动压、潮气量和死腔分数无临床显著差异,而正常碳酸血症组的呼吸频率中位数为33.0次/分,轻度高碳酸血症组为28.0次/分(p < 0.001)。90天内死亡情况显示,正常碳酸血症组292名患者中有84名死亡(28.8%),轻度高碳酸血症组292名患者中也有84名死亡(28.8%)(log-rank p = 0.842)。在老年(≥65岁)和肥胖(BMI ≥30 kg/m2)等亚组中,该结果依然成立。结论指出,在接受肺保护性通气的ARDS患者中,通过增加呼吸频率实现的正常碳酸血症并未显示出比轻度高碳酸血症更低的死亡率。由于该发现源自试验模拟,考虑到潜在显著残留偏倚的风险,解释时应持谨慎态度。
Remifentanil provides effective analgesia during invasive mechanical ventilation (IMV), but its utility is limited by opioid-related adverse events. Oliceridine, a G protein-biased μ-opioid receptor agonist, may decouple analgesia from these effects, but lacks evidence in critically ill patients. This multicentre, assessor- and patient-blinded, non-inferiority randomised controlled trial was conducted across 19 intensive care units (ICUs) in China. Adults receiving IMV were randomised 1:1 to oliceridine or remifentanil, titrated to a Critical-Care Pain Observation Tool score below 3. The primary endpoint was time in target analgesic range (TTR; non-inferiority margin -10%). Of 307 randomised patients, 304 comprised the modified intention-to-treat population (151 oliceridine, 153 remifentanil). Median TTR was 96.0% versus 92.3% (absolute difference 3.7%, 95% CI -0.3-5.7%). Oliceridine was associated with fewer mild-to-moderate adverse drug reactions (ADRs), occurring at 15.9 versus 22.2 events per 100 patient-days (IRR 0.72, 95% CI 0.52-1.00, P = 0.049), and a lower rate of respiratory depression during the study period (0% vs. 4.6%, P = 0.015). Post-extubation respiratory depression (0% vs. 7.9%, P = 0.005) and analgesic-sedation costs were both lower with oliceridine. IMV duration, ICU stay, and 28-day mortality did not differ. Subgroup analyses identified a nominal ADR benefit in patients with Acute Physiology and Chronic Health Evaluation II > 17 and a larger nominal TTR difference in those without acute respiratory distress syndrome. Oliceridine provides non-inferior analgesia to remifentanil with a more favourable respiratory safety profile and lower costs in critically ill adults. ClinicalTrials.gov NCT06454292 (registered June 11, 2024).
中文摘要:瑞芬太尼在侵入性机械通气期间可提供有效镇痛,但其应用受限于阿片类药物相关的不良事件。奥立瑞定作为G蛋白偏向性μ阿片受体激动剂,可能使镇痛作用与这些效应解耦,但在重症患者中尚缺乏证据。本研究是一项多中心、评估者与患者双盲的非劣效随机对照试验,在中国19个重症监护室进行。接受机械通气的成人患者按1:1比例随机分配至奥立瑞定组或瑞芬太尼组,滴定目标为重症监护疼痛观察工具评分低于3分。主要终点为目标镇痛范围内的时间占比(非劣效界值为-10%)。在307名随机化患者中,304名纳入改良意向性治疗人群(奥立瑞定组151例,瑞芬太尼组153例)。中位目标范围内时间占比为96.0%对92.3%(绝对差异3.7%,95%置信区间-0.3至5.7)。奥立瑞定与较少的轻中度药物不良反应相关,发生率为每100患者日15.9次对22.2次(发生率比0.72,95%置信区间0.52-1.00,P=0.049),且研究期间呼吸抑制发生率较低(0%对4.6%,P=0.015)。拔管后呼吸抑制发生率(0%对7.9%,P=0.005)及镇痛镇静成本在奥立瑞定组均较低。机械通气时间、重症监护室住院时间及28天死亡率无差异。亚组分析显示,急性生理与慢性健康状况评分II大于17的患者有名义上的不良反应获益,而无急性呼吸窘迫综合征的患者目标范围内时间占比差异更大。奥立瑞定在重症成人中提供与非劣效于瑞芬太尼的镇痛效果,具有更优的呼吸安全性特征及较低的成本。ClinicalTrials.gov编号NCT06454292(注册日期2024年6月11日)。
Frailty is associated with worse outcomes after coronary artery bypass grafting (CABG). However, the comparative effectiveness of off-pump CABG (OPCAB) versus on-pump CABG (ONCAB) in prefrail and frail patients remains uncertain. This multicenter, randomized, open-label trial enrolled patients ≥60 years of age classified as prefrail or frail, randomized 1:1, between January 2018 and December 2024. The primary outcome was a 30-day composite of death, myocardial infarction, stroke, renal failure, acute respiratory distress syndrome, or reoperation for bleeding. Secondary outcomes included ventilation time, intensive care unit and hospital stay, transfusion requirements, completeness of revascularization, surgical wound infection at 30 days, and neurocognitive function preoperatively and at 1 year. Analyses followed the intention-to-treat principle; relative risks with 95% CIs were estimated. A total of 508 patients were included (OPCAB, n=258; ONCAB, n=250; median age, 68 years [interquartile range, 65.0-73]; 30.5% female). The primary composite outcome occurred in 28 patients receiving OPCAB (10.9%) and 40 patients receiving ONCAB (16.0%; relative risk, 1.47 [95% CI, 0.94-2.31]; P=0.09). Surgical wound infection was more frequent with ONCAB (20 [8.0%] versus 9 [3.5%]; P=0.04). No significant differences were observed in neurocognitive or quality of life outcomes at 1 year. Estimated 1-year survival probabilities were 96.1% and 92.8% in the OPCAB and ONCAB groups, respectively (P=0.099). In prefrail and frail patients undergoing CABG, OPCAB and ONCAB resulted in similar rates of the primary composite outcome. No significant differences between OPCAB and ONCAB were found in neurocognitive outcomes. URL: https://www.clinicaltrials.gov; Unique identifier: NCT02338947.
中文摘要:衰弱与冠状动脉旁路移植术(CABG)后较差的预后相关。然而,术前衰弱和衰弱患者中非体外循环CABG(OPCAB)与体外循环CABG(ONCAB)的比较有效性仍不确定。这项多中心随机开放标签试验于2018年1月至2024年12月期间招募了年龄≥60岁且被分类为术前衰弱或衰弱的患者,按1:1比例随机分组。主要结局是30天内死亡、心肌梗死、卒中、肾衰竭、急性呼吸窘迫综合征或因出血再次手术的复合终点。次要结局包括通气时间、重症监护病房和住院天数、输血需求、血运重建的完整性、30天时手术切口感染以及术前和1年时的神经认知功能。分析遵循意向性治疗原则;估算相对风险及95%置信区间。共纳入508名患者(OPCAB组n=258;ONCAB组n=250;中位年龄68岁[四分位距65.0-73];女性占30.5%)。接受OPCAB的28名患者(10.9%)和接受ONCAB的40名患者(16.0%)出现了主要复合结局(相对风险1.47[95%CI 0.94-2.31];P=0.09)。ONCAB组的手术切口感染发生率更高(20例[8.0%]对比9例[3.5%];P=0.04)。在1年时未观察到神经认知或生活质量结局的显著差异。OPCAB组和ONCAB组的估计1年生存概率分别为96.1%和92.8%(P=0.099)。在接受CABG的术前衰弱和衰弱患者中,OPCAB和ONCAB的主要复合结局发生率相似。在神经认知结局方面未发现OPCAB与ONCAB之间的显著差异。
基础研究 (1篇)
ARDS comprises distinct inflammatory subphenotypes, including hyper- and hypo-inflammatory forms. Whether these differ in ventilation/perfusion (V/Q) mismatch and response to ventilatory strategies remains unclear. Dual-energy CT enables regional assessment of aeration and perfusion. This experimental study aimed to compare V/Q mismatch between hyper- and hypo-inflammatory subphenotypes, and respective responses to PEEP and prone positioning. In 10 pigs, hypo-inflammatory ARDS was induced by lung lavage followed by injurious ventilation. Hyper-inflammatory ARDS was produced by i.v. endotoxin infusion and fluid loading. Pigs were randomised to hypo- or hyperinflammatory ARDS, with similar oxygenation impairment. Dual-energy CT scans were obtained at individualised low, optimal, and high PEEP settings, in supine and prone positions. V/Q was derived from regional gas and blood volume and classified as low (<0.5), normal, or high (>2). Linear mixed-effects models included injury group, PEEP, and posture as fixed effects, and subject as a random effect. Hyper-inflammatory injury showed more severe V/Q mismatch than hypo-inflammatory injury (normal V/Q: 35% [sd=10] vs 51% [8] at low PEEP, supine position; P<0.01). Both PEEP optimisation and prone positioning improved V/Q. Prone positioning reduced high V/Q and dead space in hypo-inflammatory injury (group×posture interaction: F1,50=4.32, P=0.04), whereas PEEP reduced low V/Q and shunt in the supine position independent of ARDS subphenotype. In porcine models of hyper- and hypo-inflammatory ARDS, hyper-inflammatory injury was associated with more severe V/Q mismatch despite similar oxygenation. Distinct responses to PEEP and prone positioning support a subphenotype-tailored approach to ventilatory management.
中文摘要:急性呼吸窘迫综合征包含不同的炎症亚型,包括高炎症和低炎症形式。这些亚型在通气/灌注不匹配及呼吸机策略反应上的差异尚不明确。双能CT可实现对充气与灌注的区域性评估。本实验研究旨在比较高、低炎症亚型间的通气/灌注不匹配情况及其对呼气末正压和俯卧位通气的反应。在10头猪中,通过肺灌洗联合损伤性通气诱导低炎症急性呼吸窘迫综合征。静脉输注内毒素并补液产生高炎症急性呼吸窘迫综合征。猪被随机分配至低或高炎症亚型组,两组氧合损害程度相似。在个体化低、最佳和高呼气末正压设置下,分别采集仰卧位和俯卧位的双能CT扫描图像。通气/灌注基于区域气体和血容量计算,分为低(小于0.5)、正常或高(大于2)。线性混合效应模型将损伤组别、呼气末正压和体位作为固定效应,受试者作为随机效应。结果显示,高炎症损伤的通气/灌注不匹配比低炎症损伤更严重(低呼气末正压仰卧位时正常通气/灌注比例:35% [标准差10] 对比 51% [8];P小于0.01)。优化呼气末正压和俯卧位均能改善通气/灌注。俯卧位降低了低炎症损伤中的高通气/灌注和无死腔(组别与体位交互作用:F1,50=4.32,P=0.04),而呼气末正压则在仰卧位时独立于急性呼吸窘迫综合征亚型降低低通气/灌注和分流。在高、低炎症急性呼吸窘迫综合征的猪模型中,尽管氧合相似,高炎症损伤与更严重的通气/灌注不匹配相关。对呼气末正压和俯卧位的不同反应支持采用针对亚型的个体化通气管理策略。
3重症营养与其他 (5篇)
临床研究 (5篇)
Language barriers are associated with differences in care delivery processes and outcomes in critical care settings, with differences despite language assistance services. Less is known about outcomes associated with language concordant care. Language concordance is a linguistic match between a patient's preferred language and the language used by their care team. We undertook a systematic review to examine the measurement and impact of language concordant care delivery during critical illness, inclusive of the critical care recovery period after hospitalization. A systematic review was conducted in PubMed, CINAHL, PsycINFO, Embase, and Cochrane of English-language publications from database inception to March 3, 2026. Studies that investigated adults in critical care and post-ICU recovery clinic settings that included measurement of language concordance were included. Study quality was evaluated by the Joanna Briggs Institute Critical Appraisal Checklist. Of 1,682 unique records identified, 11 were eligible for inclusion (128,181 total patients; mean [sd] age, 68.4 [17.9 yr]; 72,872 [56.9%] male and 55,082 [43.1%] female). Six studies assessed clinical decision-making. Reported outcomes included code status changes, family conferences, communication complexity, delirium, length of stay, mechanical ventilation, and mortality. Due to significant heterogeneity in study analyses and reported outcomes, data were not pooled for quantitative analysis. Current evidence suggests that language-concordant care may influence clinically meaningful processes of critical care, warranting interventional studies to guide care delivery recommendations.
中文摘要:语言障碍与重症监护环境中护理交付过程和结果的差异相关,即使存在语言辅助服务,这种差异依然存在。关于语言一致性与结果之间的关系知之甚少。语言一致性是指患者首选语言与其护理团队所用语言之间的匹配。我们进行了一项系统评价,以考察危重疾病期间及住院后重症监护恢复期的语言一致性护理交付的测量方法和影响。我们在PubMed、CINAHL、PsycINFO、Embase和Cochrane数据库中检索了从建库至2026年3月3日的英文出版物。纳入的研究调查了重症监护和ICU后恢复门诊环境中的成年人,并包含对语言一致性的测量。研究质量由Joanna Briggs Institute关键评估清单进行评估。在确定的1682条独特记录中,有11项符合纳入标准(共128181名患者;平均年龄68.4岁,标准差17.9年;男性72872人占56.9%,女性55082人占43.1%)。六项研究评估了临床决策。报告的结局包括抢救状态改变、家庭会议、沟通复杂性、谵妄、住院天数、机械通气和死亡率。由于研究分析和报告结局存在显著的异质性,数据未进行定量合并分析。现有证据表明,语言一致性护理可能影响重症监护中具有临床意义的过程,这需要干预性研究来指导护理交付建议。
Determine whether inviting families to participate in structured, multidisciplinary rounding in the ICU can lead to improved quality of information shared and greater overall confidence in the care delivered to patients. Pre- and postimplementation observational study based on surveys provided by the Society of Critical Care Medicine-Patient-Centered Outcomes Research Institute initiative. Academic teaching hospital with 21 medical (closed unit) and 25 surgical (open unit) ICU beds. Family members and care providers of critically ill adults of 18 years and older. Families and clinicians were surveyed before and after implementation of a quality initiative to promote greater patient and family-centeredness in daily ICU rounds, using a structured and scripted rounding template. Additional information was gathered regarding provider attitudes toward the incorporation of families in rounds. In pre-and postintervention periods, 36 and 28 families were surveyed in the MICU, and 44 and 42 families were surveyed in the SICU, respectively. In pre-and postintervention periods, respectively, 53 and 48 clinicians were surveyed in the MICU, and 46 and 28 clinicians were surveyed in the SICU. Clinician perceptions improved favorably in the MICU, with statistically significant improvements falling under the category of family welcoming, presence, and participation in decision-making; less so in the SICU. Family perceptions improved in almost all parameters in the MICU, with statistical significance achieved in perceived interest in patient needs, control of agitation and pain, and consistency and honesty of information shared. Similar patterns were observed in the SICU but did not reach statistical significance. Structured, multi-disciplinary rounding with regular inclusion of family members and bedside nurses was associated with significantly greater family confidence in the quality and honesty of information shared, and an increase in perceived compassion in the care provided by ICU staff. Clinician perceptions regarding family inclusion on rounds were generally positive.
中文摘要:本研究旨在确定邀请家属参与重症监护室(ICU)的结构化多学科查房是否能提高信息共享质量并增强对患者护理的整体信心。这是一项基于美国重症医学会-以患者为中心的结果研究所倡议的调查的干预前后观察性研究,开展于一所拥有21张内科(封闭单元)和25张外科(开放单元)ICU床位的学术教学医院,研究对象为18岁及以上危重成人患者的家属及护理人员。在实施旨在促进日常ICU查房中患者及家属中心地位的质量改进项目前后,对家属和临床医生进行了调查,使用了结构化和脚本化的查房模板。此外还收集了关于临床医生对将家属纳入查房的态度的额外信息。在干预前和干预后阶段,内科ICU分别调查了36户和28户家庭,外科ICU分别调查了44户和42户家庭。在干预前和干预后阶段,内科ICU分别调查了53名和48名临床医生,外科ICU分别调查了46名和28名临床医生。内科ICU的临床医生感知结果呈有利改善,其中家庭欢迎、在场及参与决策方面的改善具有统计学意义;外科ICU的改善程度较低。内科ICU的家庭感知在几乎所有参数上均有改善,其中对患者需求的关注、对激动和疼痛的控制以及信息共享的一致性和诚实性方面达到了统计学显著性。外科ICU观察到类似的模式但未达到统计学显著性。定期纳入家属和床边护士的结构化多学科查房与家庭对信息共享质量和诚实性的信心显著增强以及认为ICU医护人员提供的护理更具同情心相关。临床医生对家属参与查房的感知总体上是积极的。
Delirium is an abnormal mental status, commonly occurring among critically ill patients, in which a person's attention and awareness change acutely. Delirium is associated with negative outcomes, including death. Furthermore, a longer duration of delirium is associated with long-term cognitive impairment in survivors of critical illness. Hence, there is a need for novel interventions that reduce the duration of delirium; however, measuring and analyzing "duration of delirium" as an endpoint in randomized trials is challenging due to the episodic nature of delirium and the competing events of coma and death, which can bias analyses of duration of delirium. Given these challenges, delirium trials have adopted one of two composite endpoints: delirium- and coma-free days, defined as the number of days alive without delirium or coma for both survivors and nonsurvivors, and an alternative composite that ranks death as the worst state and orders days alive without delirium or coma among survivors. To date, these composite endpoints have not been rigorously evaluated. Hence, herein we use data from the Maximizing Efficacy of Targeted Sedation and Reducing Neurologic Dysfunction (MENDS) trial to motivate the use of composite endpoints in critical care delirium trials, discuss how to define the effect of treatment on each composite endpoint and their clinical interpretability, and present a method for visualizing how the treatment effects accrue over the course of follow-up. Based on these analyses, we provide practical recommendations for the use of composite endpoints in critical care delirium trials, which could be extended to other randomized trials that rely on similar composite endpoints.
中文摘要:谵妄是一种异常的精神状态,常见于危重患者,表现为注意力和意识急性改变。谵妄与不良结局包括死亡相关。此外,谵妄持续时间较长与幸存者长期认知障碍相关。因此,需要新的干预措施来缩短谵妄持续时间;然而,由于谵妄的发作性质以及昏迷和死亡的竞争事件可能使分析产生偏倚,在随机试验中将「谵妄持续时间」作为终点进行测量和分析具有挑战性。鉴于这些挑战,谵妄试验采用了两种复合终点之一:无谵妄和无昏迷天数,定义为幸存者和非幸存者存活且无谵妄或昏迷的天数;以及另一种将死亡列为最差状态并排序幸存者无谵妄或昏迷天数的替代复合终点。迄今为止,这些复合终点尚未得到严格评估。因此,本文利用 Maximizing Efficacy of Targeted Sedation and Reducing Neurologic Dysfunction (MENDS) 试验的数据,旨在推动在重症监护谵妄试验中使用复合终点,讨论如何定义治疗对每种复合终点的影响及其临床可解释性,并提出一种可视化随访期间治疗效果累积的方法。基于这些分析,我们为在重症监护谵妄试验中使用复合终点提供了实用建议,这些建议可扩展至依赖类似复合终点的其他随机试验。
During sepsis, circulating cell-free mitochondrial DNA (ccf-mtDNA) is released and elevated due to cell injury, augments the immune response, and may contribute to organ dysfunction. Delirium is common and deleterious during sepsis, but little is known about the relationship between mitochondrial injury and delirium during sepsis. We sought therefore to examine associations between ccf-mtDNA and delirium and other clinical outcomes during sepsis. Multicenter, prospective cohort study. Medical and surgical ICUs in university and community hospitals in Nashville, TN. Four hundred eighty patients with sepsis plus shock and/or acute respiratory failure. None. We measured ccf-mtDNA in plasma collected on multiple days (study days 1, 3, and 5) during sepsis and assessed participants bid for delirium and coma using the validated Confusion Assessment Method for the ICU and Richmond Agitation-Sedation Scale. We then assessed survivors' cognitive function 3 and 12 months after hospital discharge using the Repeatable Battery for the Assessment of Neuropsychological Status. During sepsis, the adjusted odds of delirium were 7% lower for individuals at the 75th percentile of ccf-mtDNA compared with those at the 25th percentile (odds ratio [OR], 0.93; 95% CI, 0.86-0.99; p = 0.048). ccf-mtDNA was marginally associated with in-hospital mortality (hazard ratio, 1.09; 95% CI, 0.99-1.20; p = 0.08), but was not associated with coma (OR, 0.98; 95% CI, 0.90-1.05; p = 0.31) or 3-month (beta, 0.23; 95% CI, -1.58 to 2.05; p = 0.80) and 12-month (beta, -0.36; 95% CI, -2.13 to 1.42; p = 0.69) cognitive outcomes. In this multicenter, prospective cohort study, higher levels of ccf-mtDNA were associated with lower odds of delirium, a result that contradicted our hypothesis. This provocative finding should be interpreted cautiously until replicated and explained by future studies.
中文摘要:在脓毒症期间,循环游离线粒体DNA(ccf-mtDNA)因细胞损伤而释放并升高,增强免疫反应,并可能导致器官功能障碍。谵妄在脓毒症期间常见且有害,但关于脓毒症期间线粒体损伤与谵妄之间关系的研究甚少。因此,我们旨在探讨脓毒症期间ccf-mtDNA与谵妄及其他临床结局之间的关联。这是一项多中心前瞻性队列研究。研究对象为田纳西州纳什维尔大学医院和社区医院内科及外科重症监护室(ICU)的480名患有脓毒症合并休克和/或急性呼吸衰竭的患者。我们在脓毒症期间收集了患者多个时间点(研究第1、3和5天)的血浆样本,测量其中的ccf-mtDNA水平,并使用经过验证的ICU混淆评估法和里士满躁动-镇静量表每日两次评估参与者的谵妄和昏迷状态。随后,我们使用神经心理状态重复电池量表评估出院后3个月和12个月幸存者的认知功能。在脓毒症期间,与处于ccf-mtDNA第25百分位数的个体相比,处于第75百分位数的个体发生谵妄的调整后几率低7%(比值比[OR]为0.93;95%置信区间[CI]为0.86-0.99;p=0.048)。ccf-mtDNA与院内死亡率存在边缘关联(风险比[HR]为1.09;95% CI为0.99-1.20;p=0.08),但与昏迷(OR为0.98;95% CI为0.90-1.05;p=0.31)以及3个月(beta为0.23;95% CI为-1.58至2.05;p=0.80)和12个月(beta为-0.36;95% CI为-2.13至1.42;p=0.69)的认知结局无关联。在这项多中心前瞻性队列研究中,较高水平的ccf-mtDNA与较低的谵妄几率相关,这一结果与我们的假设相矛盾。在得到未来研究的重复和解释之前,应谨慎解读这一发人深省的结果。
Delirium is a common yet underrecognized neuropsychiatric syndrome in cardiovascular medicine associated with prolonged hospitalization, increased mortality, and long-term cognitive decline. Patients undergoing interventional or surgical cardiovascular procedures-such as transcatheter aortic valve replacement, surgical aortic valve replacement, coronary artery bypass grafting, or percutaneous coronary interventions-may be particularly vulnerable to its development. Delirium incidence varies widely across cardiovascular procedures, influenced by patient characteristics, procedural invasiveness, and diagnostic methodology. Risk factors include advanced age, baseline cognitive impairment, cerebrovascular disease, extended operative times, perioperative complications, and systemic inflammation. Diagnostic tools such as the Confusion Assessment Method (CAM) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score are established but underutilized in the diagnosis of delirium. While preventive strategies emphasizing non-pharmacological, multicomponent approaches-such as early mobilization, cognitive stimulation, and sleep hygiene-are supported by strong evidence, preventive use of pharmacologic agents remains controversial. Pharmacologic treatment is reserved for select cases; dexmedetomidine shows benefits in intensive care unit settings, while antipsychotics like quetiapine and risperidone may be used cautiously. Overall, delirium poses a significant clinical challenge in cardiovascular medicine and requires a proactive, interdisciplinary approach. Systematic risk assessment and multimodal preventive strategies should be the standard of care, while pharmacologic treatment should be symptom- and context-specific. Further high-quality studies are needed to inform evidence-based guidelines tailored to cardiovascular populations. The present state-of-the-art review summarizes the current literature on the epidemiology, mechanisms, clinical manifestations, diagnosis, prevention, and treatment of delirium in cardiovascular medicine. By integrating findings and interdisciplinary expert discussions from interventional cardiology, cardiac surgery, and psychiatry, it aims to define the unique vulnerability of this patient population, highlight critical knowledge gaps, and lay the foundation for developing targeted, evidence-based management strategies.
中文摘要:谵妄是心血管医学中一种常见但常被忽视的神经精神综合征,与住院时间延长、死亡率增加及长期认知功能下降相关。接受介入或外科手术(如经导管主动脉瓣置换术、外科主动脉瓣置换术、冠状动脉旁路移植术或经皮冠状动脉介入治疗)的患者可能更易发生谵妄。谵妄发生率因心血管手术类型而异,受患者特征、手术侵入性及诊断方法影响。危险因素包括高龄、基线认知障碍、脑血管疾病、手术时间延长、围术期并发症及全身炎症。虽然混淆评估法(CAM)和重症监护病房混淆评估法(CAM-ICU)评分是公认的诊断工具,但在谵妄诊断中应用不足。预防策略强调非药物性多组分方法(如早期活动、认知刺激和睡眠卫生),证据充分;而药物的预防性使用仍存在争议。药物治疗仅保留给特定病例;右美托咪定在重症监护病房环境中显示益处,而喹硫平和利培酮等抗精神病药需谨慎使用。总体而言,谵妄是心血管医学中重大的临床挑战,需要主动的多学科方法。系统性风险评估和多模态预防策略应成为标准护理,药物治疗应基于症状和具体情境。需要更多高质量研究以制定针对心血管人群的证据导向指南。本前沿综述总结了心血管医学中谵妄的流行病学、机制、临床表现、诊断、预防和治疗的现有文献,整合了介入心脏病学、心脏外科和精神病学领域的发现及多学科专家讨论,旨在界定该患者群体的独特易感性,突出关键知识空白,并为开发靶向证据管理策略奠定基础。
4急诊医学与院前急救 (5篇)
临床研究 (3篇)
Effective stroke prevention relies on identifying at-risk individuals before neurological symptoms arise, yet this is severely limited by the absence of scalable screening tools. To address this, we developed RetCEVD, a diagnostic framework that uses rapid, non-invasive retinal Optical Coherence Tomography Angiography (OCTA) for auxiliary assessment of ICVD. At its core, RetCEVD introduces a memory-guided mutual information optimization strategy that maximizes shared disease-relevant information within the same diagnostic category while suppressing redundant or confounding dependencies across different categories. This dual information constraint encourages compact, discriminative representations of subtle retinal microvascular abnormalities. Trained and validated on a multi-center cohort of 24,438 retinal images, RetCEVD addresses three primary tasks: auxiliary detection of existing ICVD, etiological subtyping (large artery atherosclerosis vs. small vessel disease), and current symptomatic-status classification (asymptomatic vs. symptomatic LAA). The model achieved AUCs of 0.95 internal and 0.94 external for ICVD detection, 0.83 internal and 0.81 external for etiological subtyping, and 0.75 internal and 0.76 external for current symptomatic-status classification. The two-year ALAA follow-up provided supplementary longitudinal validation for subsequent stroke events (AUC, 0.71). By comprehensively evaluating the model's clinical interpretability, including its learned pathological features and alignment with established clinical patterns, we provide novel insights into retina-based stroke evaluation. Ultimately, RetCEVD may serve as an efficient, low-cost screening and triage tool to identify individuals who may benefit from confirmatory neurovascular imaging and specialist assessment.
中文摘要:有效的卒中预防依赖于在神经系统症状出现前识别高风险个体,但这一目标因缺乏可扩展的筛查工具而受到严重限制。为解决这一问题,我们开发了RetCEVD诊断框架,利用快速、非侵入性的视网膜光学相干断层扫描血管成像(OCTA)对缺血性心血管病(ICVD)进行辅助评估。RetCEVD的核心是一种记忆引导的互信息优化策略,该策略在最大化同一诊断类别内共享的疾病相关信息的同时,抑制不同类别间冗余或混淆的依赖关系。这种双重信息约束鼓励形成紧凑且具有判别力的视网膜微血管细微异常表征。基于包含24,438张视网膜图像的多中心队列进行训练和验证,RetCEVD完成了三项主要任务:现有ICVD的辅助检测、病因分型(大动脉粥样硬化与小血管病)以及当前症状状态分类(无症状与有症状的大动脉粥样硬化)。该模型在ICVD检测方面取得了0.95的内部AUC和0.94的外部AUC,在病因分型方面取得了0.83的内部AUC和0.81的外部AUC,在当前症状状态分类方面取得了0.75的内部AUC和0.76的外部AUC。为期两年的大动脉粥样硬化(ALAA)随访为后续卒中事件提供了补充性的纵向验证数据(AUC为0.71)。通过全面评估模型的临床可解释性,包括其学习的病理特征与既定临床模式的一致性,我们为基于视网膜的卒中评估提供了新见解。最终,RetCEVD可能作为一种高效、低成本的筛查和分诊工具,用于识别可能从确认性神经血管影像学和专科评估中受益的个体。
To characterize trends in hospitalization, downstream care, and outcomes among emergency department (ED) patients with chest pain without acute myocardial infarction (AMI) diagnosis. We analyzed claims data from a large national commercial insurer (2007-2021) and identified ED visits with a principal diagnosis of chest pain. We excluded visits with secondary diagnoses of AMI or other significant cardiopulmonary conditions and those preceded by cardiac testing, coronary procedures, AMI admissions, or chest pain ED visits within 6 months. Usage outcomes included index hospitalization (principal), 7-day cardiac testing, and 30-day coronary revascularization. The principal clinical outcome was 180-day postindex AMI hospitalization. Adjusted annual rates were estimated using generalized estimating equations, and trends were assessed using inverse-variance-weighted linear regression. We included 773,250 index chest pain ED visits (mean age 54.2 years; 54.3% women). Adjusted hospitalization rates declined from 42.7% to 18.6%, and 7-day noninvasive testing decreased from 26.7% to 9.1%. Revascularization within 30 days declined from 5.8% to 3.6%. Overall, 180-day postindex AMI hospitalization showed no significant temporal trend, ranging from 0.8% to 1.2%. However, a modest increasing trend was observed among patients aged 70 years and older. Among ED patients with chest pain without AMI diagnosis, hospitalization, cardiac testing, and revascularization declined substantially from 2007 to 2021. Overall, downstream AMI hospitalization remained stable, although those in older adults experienced modest rises. Although efforts continue to identify additional low-risk patients for safe discharge, future research should quantify the potential benefits of hospitalization and cardiac testing, particularly for older adults and high-risk patients.
中文摘要:本研究旨在描述无急性心肌梗死诊断的急诊科胸痛患者在住院、后续诊疗及预后方面的趋势。我们分析了大型国家商业保险公司的索赔数据(2007至2021年),并识别了以胸痛为主要诊断的急诊就诊记录。排除了次要诊断为急性心肌梗死或其他重大心肺疾病,以及此前6个月内接受过心脏检查、冠状动脉手术、心肌梗死住院或胸痛急诊就诊的记录。使用结局指标包括主要住院率(主要诊断)、7天内的心脏检查率和30天内的冠状动脉血运重建率。主要临床结局为索引后180天内因急性心肌梗死住院的情况。采用广义估计方程估算调整后的年度比率,并使用逆方差加权线性回归评估趋势。研究共纳入773,250例索引胸痛急诊就诊记录(平均年龄54.2岁;女性占54.3%)。调整后住院率从42.7%下降至18.6%,7天内非侵入性心脏检查率从26.7%下降至9.1%。30天内的血运重建率从5.8%下降至3.6%。总体而言,索引后180天内因急性心肌梗死住院的情况未显示显著的时间趋势,范围在0.8%至1.2%之间。然而,在70岁及以上患者中观察到轻微上升趋势。在无急性心肌梗死诊断的急诊胸痛患者中,从2007年至2021年,住院率、心脏检查率和血运重建率均大幅下降。总体而言,后续因急性心肌梗死住院的情况保持稳定,尽管老年人群体出现轻微上升。尽管持续努力识别更多适合安全出院的低风险患者,但未来研究应量化住院和心脏检查的潜在益处,特别是针对老年人和高危患者。
Names are important markers of identity, culture, and belonging. In health care settings, individuals with ethnically distinct names may experience repeated mispronunciations, unsolicited nicknames, or avoidance of their names. Repeated mispronunciations without sincere efforts to learn or improve, as well as the avoidance, dismissal, or replacement of names with unsolicited nicknames, may function as name-based microaggressions and can negatively affect psychological safety, professional identity formation, and workplace inclusion. In this manuscript, we discuss the effect of name-based microaggressions on health care professionals and trainees, with particular focus on the emergency department. We review the 3 major categories of microaggressions-microassaults, microinsults, and microinvalidations-and use clinical vignettes to demonstrate how these behaviors may appear in both interpersonal and institutional settings. We also propose practical interpersonal and institutional strategies to promote more inclusive workplaces and foster respectful engagement with ethnically distinct names. By encouraging greater awareness, curiosity, humility, and intentionality around names, health care organizations can help cultivate clinical environments where individuals feel respected, included, and valued.
中文摘要:姓名是身份、文化和归属感的重要标志。在医疗环境中,拥有族裔特征鲜明姓名的个体可能会经历反复的误读、未经同意的昵称或被回避使用姓名。缺乏真诚努力去学习或改进的反复误读,以及通过未经同意的昵称来回避、忽视或替换姓名,可能构成基于姓名的微侵略行为,并对心理安全感、职业身份形成和职场包容性产生负面影响。本文讨论了基于姓名的微侵略对医疗专业人员及受训者的影响,重点聚焦于急诊科。我们回顾了微侵略的三大主要类别:微攻击、微侮辱和微无效化,并利用临床案例说明这些行为在人际和机构环境中可能呈现的形式。我们还提出了促进更包容职场和培养对族裔特征鲜明姓名尊重的互动与机构策略。通过鼓励对姓名保持更高的意识、好奇心、谦逊和意图性,医疗机构可以帮助营造让个体感到被尊重、包容和重视的临床环境。
基础研究 (2篇)
Rapid clinical decision-making for acute myocardial infarction (AMI) relies on the timely and precise assessment of cardiac biomarkers. However, detecting cardiac troponin I (cTnI), as the gold-standard biomarker for AMI, with both laboratory-grade sensitivity and rapid clinical turnaround remains a formidable challenge in point-of-care (POC) settings. To address this, we develop a one-pot surface-enhanced Raman scattering (SERS) aptasensor that integrates aptamer-mediated cTnI recognition, catalytic hairpin assembly (CHA) amplification, and plasmonic hotspot assembly. The assay supports two kinetic operating modes within the same assay: a 60-min high-sensitivity mode with a serum limit of detection (LOD) of 53.58 fg/mL and a 20-min rapid-triage mode with an LOD of 14.25 pg/mL, below the clinical decision threshold of 40 pg/mL. In a cohort of 100 clinical serum samples, the bootstrap optimism-corrected diagnostic accuracy was 91.3% for the SERS aptasensor, significantly outperforming conventional ELISA (77.8%). In a subset of 94 subjects with available routine cTnT results, the SERS-cTnI assay achieved an area under the receiver operating characteristic curve (AUC) of 0.988, comparable to that of the hospital's routine chemiluminescence cTnT assay (0.976), supporting its potential as a complementary diagnostic tool for cTnI-based AMI assessment. Furthermore, compatibility with a handheld Raman spectrometer was evaluated in an independent validation cohort (n = 36), achieving 97.2% accuracy using only 4 μL of serum within 20 min following serum preparation. This reliable one-pot SERS platform bridges ultra-sensitive detection and rapid portable readout, holding promise as a potential tool for future decentralized cardiovascular POC diagnostics.
中文摘要:急性心肌梗死(AMI)的快速临床决策依赖于对心脏生物标志物的及时且精确的评估。然而,在即时检测(POC)环境中,同时具备实验室级灵敏度和快速临床周转时间的肌钙蛋白I(cTnI)检测仍是一项严峻挑战。为解决这一问题,我们开发了一种一表面增强拉曼散射(SERS)适体传感器,该传感器整合了适体介导的cTnI识别、催化发夹组装(CHA)扩增以及等离子体热点组装。该检测方法在同一实验中支持两种动力学操作模式:一种为耗时60分钟的高灵敏度模式,血清检测限(LOD)为53.58 fg/mL;另一种为耗时20分钟的快速分诊模式,LOD为14.25 pg/mL,低于40 pg/mL的临床决策阈值。在100例临床血清样本队列中,SERS适体传感器的Bootstrap乐观校正诊断准确率为91.3%,显著优于传统ELISA(77.8%)。在包含94名具有常规cTnT结果受试者的子集中,SERS-cTnI检测法获得的受试者工作特征曲线下面积(AUC)为0.988,与医院常规化学发光cTnT检测法(0.976)相当,支持其作为基于cTnI的AMI评估补充诊断工具的潜力。此外,在独立验证队列(n=36)中评估了其与手持式拉曼光谱仪的兼容性,仅使用4 μL血清并在制备后20分钟内即实现了97.2%的准确率。这一可靠的一SERS平台弥合了超灵敏检测与快速便携式读数之间的差距,有望成为未来去中心化心血管POC诊断的工具。
Experimental measurements of protein thermodynamic stability are essential for understanding the relationship between protein structure and function, the molecular consequences of mutations, and their potential implications for protein malfunction and disease. However, extracting these data from the literature remains constrained by labor-intensive manual curation. Here, we present ThermoMutDB 2.0, a scalable framework for semiautomated literature curation and systematic structural enrichment. It introduces a major architectural redesign that integrates a large language model with rule-based entity recognition to identify and prioritize publications reporting experimentally measured effects of protein mutations on thermostability, while retaining expert validation as the final curation step. Complementing this literature-processing workflow, ThermoMutDB 2.0 systematically enriches curated mutations with mutant structural models, enabling interactive three-dimensional contextualization of experimentally derived thermodynamic data. Applied to the literature retrieved from January 1976 to the most recent search update in 2026, the pipeline screened 5,934 candidate publications and prioritized 254 for expert review, resulting in the incorporation of 102 articles and 1763 new entries. Rather than representing a simple expansion of database content, ThermoMutDB 2.0 establishes an extensible human-in-the-loop architecture in which automated literature triage, expert curation, and structural modeling operate as an integrated workflow. This redesign provides a sustainable foundation for continuous database maintenance and for linking experimental protein stability measurements with their structural context (available at http://thermomutdb.pathotrack.health/).
中文摘要:蛋白质热力学稳定性的实验测量对于理解蛋白质结构与功能的关系、突变的分子后果及其对蛋白质功能障碍和疾病的潜在影响至关重要。然而,从文献中提取这些数据仍受限于劳动密集型的手工整理工作。本文提出了ThermoMutDB 2.0,这是一个用于半自动化文献整理和系统性结构富集的可扩展框架。该框架引入了重大的架构重新设计,将大型语言模型与基于规则的实体识别相结合,以识别并优先筛选报告蛋白质突变对热稳定性影响的实验测量结果的出版物,同时保留专家验证作为最终的整理步骤。配合这一文献处理工作流程,ThermoMutDB 2.0通过突变结构模型系统地富集了已整理的突变数据,实现了实验得出的热力学数据的交互式三维背景化。应用于从1976年1月到2026年最近一次搜索更新期间检索到的文献,该流程筛选了5,934篇候选出版物并优先选择了254篇供专家审查,最终纳入了102篇文章和1763个新条目。ThermoMutDB 2.0并非简单的数据库内容扩展,而是建立了一个可扩展的人机协作架构,其中自动化文献初筛、专家整理和结构建模作为集成工作流程运行。这一重新设计为持续的数据库维护以及将实验性蛋白质稳定性测量与其结构背景联系起来提供了可持续的基础(网址:http://thermomutdb.pathotrack.health/)。
5心肺复苏与心脏骤停 (5篇)
临床研究 (4篇)
To evaluate the prognostic implications of rhythm transitions between asystole and pulseless electrical activity (PEA) in out-of-hospital cardiac arrest (OHCA) patients with initial nonshockable rhythms. Nationwide population-based observational study. Nationwide OHCA Registry of South Korea, managed by the Korea Disease Control and Prevention Agency. Consecutive adult (≥ 18 yr old) OHCA patients with nonshockable rhythms from January 1, 2016 to December 31, 2021. None. Patients were categorized into four groups based on rhythm changes during cardiopulmonary resuscitation (CPR): asystole-to-asystole (A-A), asystole-to-PEA (A-P), PEA-to-asystole (P-A), and PEA-to-PEA (P-P). The primary outcome was good neurologic outcome at hospital discharge, defined as a Cerebral Performance Category score of 1-2. Inverse probability of treatment weighting (IPTW) was used to adjust for measured confounding. In the primary IPTW model, weighted risks of good neurologic outcome were 0.101% in A-A, 0.231% in A-P, 0.384% in P-A, and 0.874% in P-P. Compared with A-A, the odds of good neurologic outcome were higher in A-P (odds ratio [OR], 2.28; 95% CI, 1.78-2.93; risk difference [RD], 0.130 percentage points), P-A (OR, 3.80; 95% CI, 3.01-4.80; RD, 0.283 percentage points), and P-P (OR, 8.70; 95% CI, 6.98-10.83; RD, 0.773 percentage points). Compared with A-P, P-A had higher odds of good neurologic outcome (OR, 1.66; 95% CI, 1.39-1.99; RD, 0.153 percentage points). Asystole conversion to PEA during CPR was associated with a better neurologic outcome than persistent asystole. Although transitioning from PEA to asystole was associated with lower odds of a good outcome compared with persistent PEA, it was associated with a better outcome than A-P transitions. Recognizing these patterns may provide prognostic context beyond a single rhythm assessment.
中文摘要:目的:评估初始非可电击心律院外心脏骤停患者中,心室停搏与无脉性电活动之间节律转换的预后意义。设计:全国性人群观察性研究。数据来源:由韩国疾病管理厅管理的韩国全国院外心脏骤停登记数据库。对象:2016年1月1日至2021年12月31日期间连续入组的非可电击心律成人(≥18岁)院外心脏骤停患者。干预措施:无。分组方法:根据心肺复苏期间的节律变化将患者分为四组:心室停搏至心室停搏、心室停搏至无脉性电活动、无脉性电活动至心室停搏、无脉性电活动至无脉性电活动。主要结局指标:出院时良好的神经功能结局,定义为脑功能分类评分1-2分。统计方法:采用逆概率治疗加权调整测量混杂因素。结果:在主要IPTW模型中,良好神经功能结局的加权风险分别为心室停搏至心室停搏组0.101%、心室停搏至无脉性电活动组0.231%、无脉性电活动至心室停搏组0.384%、无脉性电活动至无脉性电活动组0.874%。与心室停搏至心室停搏组相比,其他三组的良好神经功能结局优势比更高,分别为2.28、3.80和8.70。与心室停搏至无脉性电活动组相比,无脉性电活动至心室停搏组的良好神经功能结局优势比更高(OR 1.66)。结论:心肺复苏期间心室停搏转换为无脉性电活动与持续心室停搏相比具有更好的神经功能结局。虽然从无脉性电活动转换至心室停搏的良好结局几率低于持续无脉性电活动,但其结局优于心室停搏至无脉性电活动的转换。识别这些模式可提供超越单一节律评估的预后背景信息。
Urgent ICU consultation is intended to elicit advice and consider ICU transfer. Our objective was to describe the nature and outcomes of ICU consultations across a global cohort. This is a secondary analysis of patients with one or more ICU consultations. A care episode was defined as consecutive urgent ICU consultations until an ICU admission or at least 2 weeks without an urgent ICU consultation. We describe consultation outcomes for the last care episode. Late escalations were defined by a Children's Resuscitation Intensity Scale score greater than 2. Twenty-one centers participating in the Evaluation of Processes of Care and the Outcomes of Children in Hospital (EPOCH) cluster-randomized trial. There were 4288 urgent ICU consultations in 3625 care episodes for 3000 patients with a median (interquartile range) age of 25 months (5-99 mo). In the parent EPOCH trial, hospitals were randomized to Bedside Pediatric Early Warning System or usual care; no intervention was assigned in this secondary analysis. The outcomes of the 3000 last care episodes were in-consultation death in three (0.1%) and urgent ICU admission in 1477 (49.2%). Among 3000 first, 400 second, and 68 third consultations, the proportions of ICU admission were 42%, 44%, and 47%. The proportions of ICU admissions that were late escalation were similar across groups: 18% for first and second urgent ICU consultations, and 25% for third urgent ICU consultations. among patients having a second urgent ICU consultation, patients who had received resuscitation interventions in their first urgent ICU consultation (and remained on the ward) had more frequent resuscitation events (23.2% vs. 3.4%, p < 0.01) and had a similar frequency of late escalation (31.8% vs. 15.6%, p = 0.07) and ICU admission (51.1% vs. 43.1%, p = 0.40) compared with patients without resuscitation in their first urgent ICU consultation. Urgent consultation to the ICU is common during pediatric hospitalization. Repeated ICU consultation was associated with a similar frequency of late escalation. Resuscitation measures were provided in one of 12 ICU consultations where patients were not admitted to ICU and were a risk factor for late escalation in subsequent consultations.
中文摘要:紧急重症监护室会诊旨在获取建议并考虑转入重症监护室。本研究旨在描述全球队列中重症监护室会诊的性质和结局。这是对参与评估医院儿童护理过程及结局(EPOCH)集群随机对照试验的21个中心中,具有至少一次重症监护室会诊的患者进行的二次分析。护理事件定义为连续的紧急重症监护室会诊,直至患者转入重症监护室或至少两周未进行紧急重症监护室会诊。我们描述了最后一次护理事件的会诊结局。晚期升级由儿童复苏强度量表评分大于2定义。3000名患者的中位年龄为25个月(四分位距5-99个月),共发生4288次紧急重症监护室会诊,涉及3625个护理事件。在父级EPOCH试验中,医院被随机分配至床旁儿科早期预警系统组或常规护理组;本二次分析未分配干预措施。3000个最后一次护理事件的结局显示,会诊期间死亡3例(0.1%),紧急转入重症监护室1477例(49.2%)。在3000例首次、400例第二次和68例第三次会诊中,转入重症监护室的比例分别为42%、44%和47%。各组晚期升级的转入比例相似:第一次和第二次紧急重症监护室会诊为18%,第三次为25%。在经历第二次紧急重症监护室会诊的患者中,与首次会诊未接受复苏治疗的患者相比,首次会诊接受过复苏治疗(且仍留在普通病房)的患者复苏事件更频繁(23.2% vs. 3.4%, p < 0.01),晚期升级频率相似(31.8% vs. 15.6%, p = 0.07),转入重症监护室的比例也相似(51.1% vs. 43.1%, p = 0.40)。紧急重症监护室会诊在儿科住院期间很常见。重复的重症监护室会诊与相似的晚期升级频率相关。在未转入重症监护室的每12次重症监护室会诊中有1次提供了复苏措施,且复苏措施是后续会诊中晚期升级的危险因素。
Medical Aid in Dying (MAID) is a legal medical option for terminally ill patients with decision-making capacity to self-administer prescription medication to cause death. MAID has expanded across the United States, with New York becoming the most recent state to legalize it in August 2026. As these medications become more available in the community, typically administered outside controlled medical settings, such as the home, rare but consequential unintended exposures can occur. MAID is distinct from euthanasia in that the patient must have decision-making capacity and must be able to self-administer the medication; this requirement contributes to the presence of highly lethal drug mixtures in nonclinical environments. Although MAID formulations are designed to be lethal, unintended recipients may ingest only a partial dose (eg, a "sip"), making survival possible with prompt medical care. We review the background and common components of MAID mixtures, which typically combine a sedative (benzodiazepine and/or barbiturate), an opioid, and cardiotoxic agents such as digoxin, β-blockers, and/or tricyclic antidepressants. We propose preliminary management guidelines for suspected unsanctioned MAID exposures: early regional poison center consultation; supportive resuscitation; activated charcoal when safe; targeted diagnostics, including serum digoxin concentration and serial electrocardiograms; gastric aspiration, when feasible; use of digoxin immune Fab when indicated; avoidance of flumazenil and naloxone in mixed ingestions; and substance-specific therapies, such as high-dose insulin for propranolol toxicity and sodium bicarbonate for tricyclic antidepressants-induced QRS widening.
中文摘要:医疗协助死亡(MAID)是具备决策能力的绝症患者自行服用处方药物以导致死亡的合法医疗选项。随着该选项在美国各州的扩展,纽约于2026年8月成为最新将其合法化的州。由于这些药物通常在家庭等非受控医疗环境中在社区内可用,罕见但后果严重的意外暴露事件可能发生。MAID与安乐死不同,患者必须具备决策能力并能自行给药,这一要求导致高致死性药物混合物存在于非临床环境中。尽管MAID配方旨在致死,但意外接触者可能仅摄入部分剂量(如一口),在及时医疗干预下仍有可能存活。本文回顾了MAID混合物的背景及常见成分,通常包括镇静剂(苯二氮䓬类和/或巴比妥酸盐)、阿片类药物以及地高辛、β受体阻滞剂和/或三环类抗抑郁药等心脏毒性药物。我们提出了针对疑似未经批准MAID暴露的初步管理指南:早期咨询区域毒物控制中心;支持性复苏;在安全情况下使用活性炭;进行针对性诊断,包括血清地高辛浓度和连续心电图检查;在可行时进行胃吸引;在指征明确时使用地高辛免疫Fab;避免在混合摄入中使用氟马西尼和纳洛酮;以及实施特定物质的治疗,如针对普萘洛尔毒性的高剂量胰岛素和针对三环类抗抑郁药引起的QRS波增宽的碳酸氢钠。
To evaluate agreement between immediate live and delayed video-based assessment of nontechnical skills during real-world adult cardiac arrest resuscitation, and whether agreement differed by rater experience. We conducted a prospective observational study of adult cardiac arrest resuscitations in a tertiary emergency department in Taiwan in 2024. For each event, one trained physician or nurse who participated in the resuscitation completed the Team Emergency Assessment Measure (TEAM) immediately afterward and re-rated the same event from video approximately 30 days later. Live-video agreement was assessed using intraclass correlation coefficients and Bland-Altman analysis. Of 105 recorded resuscitations, 80 had complete paired assessments. Mean global ratings were similar between modalities (8.25 versus 8.22; mean paired difference, -0.03; 95% confidence interval [CI] -0.25 to 0.20), whereas teamwork scores were modestly lower on video review (mean paired difference, -1.00; 95% CI -1.77 to -0.23). Event-level agreement was limited: intraclass correlation coefficients were 0.21 (95% CI 0.00 to 0.41) for total TEAM score and 0.16 (95% CI -0.06 to 0.37) for global rating. Total TEAM video ratings averaged 1.24 points lower than live ratings, with limits of agreement from -12.28 to 9.80. Agreement was higher among senior raters. Delayed video-based TEAM assessment produced similar group-level scores but limited event-level agreement during real-world cardiac arrest. Agreement appeared higher among senior raters. Video review may support debriefing and monitoring, but appraisal of a specific resuscitation or other higher stakes use likely requires experienced raters and structured safeguards.
中文摘要:旨在评估真实世界成人心脏骤停复苏过程中非技术技能的即时现场评估与延迟视频评估之间的一致性,并探讨该一致性是否因评估者经验而异。本研究为2024年在台湾某三级急诊科开展的前瞻性观察研究。针对每次事件,一名参与复苏的受训医师或护士在事后立即完成团队紧急评估措施评分,并在约30天后通过视频对同一事件进行重新评分。采用组内相关系数和Bland-Altman分析评估现场与视频评估的一致性。在105次记录的复苏事件中,80例具有完整的配对评估数据。两种模态的平均总体评分相似(分别为8.25和8.22;平均配对差异为-0.03;95%置信区间为-0.25至0.20),而团队协作得分在视频回顾时略低(平均配对差异为-1.00;95%置信区间为-1.77至-0.23)。事件层面的一致性有限:总团队紧急评估措施得分的组内相关系数为0.21(95%置信区间为0.00至0.41),总体评分的组内相关系数为0.16(95%置信区间为-0.06至0.37)。视频评估的团队紧急评估措施总分平均比现场评分低1.24分,一致性界限为-12.28至9.80。高级评估者的一致性更高。延迟视频评估在真实世界心脏骤停中产生了相似的群体水平得分,但事件层面的一致性有限。高级评估者的一致性似乎更高。视频回顾可能支持复盘和监测,但对特定复苏事件的评估或其他高风险用途可能需要经验丰富的评估者和结构化的保障措施。
基础研究 (1篇)
Polychlorinated biphenyls (PCBs) are persistent organic pollutants whose biodegradation can be constrained by the transition of indigenous PCB-degrading microorganisms into a viable but non-culturable (VBNC) state. Although resuscitation-promoting factors (Rpfs) can reactivate dormant microorganisms, the multistep production and purification of recombinant Rpf may constrain its practical application. Here, a crude autocrine Rpf-associated fraction (ca-Rpf) secreted by Achromobacter sp. HR2 was compared with recombinant Rpf (re-Rpf) for enhancing PCB biodegradation. Both treatments enhanced PCB degradation during acclimation and generated enriched cultures that retained improved degradation capacity without further Rpf supplementation. At 40 mg/L Aroclor 1242, PCB degradation efficiencies on day 18 reached 60.8% and 53.6% in the ca-Rpf- and re-Rpf-enriched cultures, respectively, compared with 40.1% in the control. Enhanced degradation was accompanied by increased Na⁺/K⁺-ATPase and cytochrome P450 activities. Metatranscriptomic analysis revealed treatment-dependent changes in the expression of genes associated with central carbon metabolism, oxidative phosphorylation, aromatic-compound degradation, and dormancy-related processes. The ca-Rpf-enriched cultures exhibited stronger transcriptional responses in several catabolic pathways, accompanied by shifts in the relative representation of putative PCB-degrading taxa, including Pseudomonas, Stenotrophomonas, and Azospirillum. These findings link enhanced PCB biodegradation to microbial community remodeling and catabolic gene transcription, highlighting the potential of endogenous Rpf-associated preparations for bioremediation.
中文摘要:多氯联苯(PCBs)是持久性有机污染物,其生物降解可能因本土PCB降解微生物进入 viable but non-culturable (VBNC) 状态而受限。尽管复苏促进因子(Rpfs)可重新激活休眠微生物,但重组Rpf的多步生产和纯化过程可能限制其实际应用。本研究比较了由产碱杆菌属HR2分泌的粗自分泌Rpf相关组分(ca-Rpf)与重组Rpf(re-Rpf)在增强PCB生物降解方面的效果。两种处理均在适应期增强了PCB降解,并生成了保留改进降解能力且无需进一步补充Rpf的富集培养物。在40 mg/L Aroclor 1242条件下,第18天ca-Rpf和re-Rpf富集培养物的PCB降解效率分别达到60.8%和53.6%,而对照组为40.1%。增强降解伴随Na⁺/K⁺-ATP酶和细胞色素P450活性增加。宏转录组分析揭示了处理依赖性的基因表达变化,涉及中心碳代谢、氧化磷酸化、芳香族化合物降解和休眠相关过程。ca-Rpf富集培养物在几个分解代谢途径中表现出更强的转录反应,同时伴随假定的PCB降解类群(包括假单胞菌属、嗜麦芽窄食单胞菌属和固氮螺菌属)相对丰度的变化。这些发现将增强的PCB生物降解与微生物群落重塑及分解代谢基因转录联系起来,突出了内源性Rpf相关制剂在生物修复中的潜力。
6中毒与环境急症 (4篇)
基础研究 (4篇)
The performance of proton exchange membrane fuel cells (PEMFCs) is critically governed by the cathodic triple-phase interface, where platinum catalyst poisoning and inefficient proton/oxygen transport severely impede the oxygen reduction reaction. Inspired by the selective transport of biological membranes, we herein develop a porphyrin-based organic network (H-PorBz) as a multifunctional ionomer modifier to reconfigure the catalyst/ionomer/gas triple-phase interface. In situ noncovalent cross-linking between the H-PorBz and Nafion via NH+-H···SO3- interactions forms an interfacial layer that decouples proton and oxygen transport while suppressing sulfonate-induced Pt poisoning. Spectroscopic and computational studies reveal that H-PorBz simultaneously enhances proton conduction and oxygen transport by establishing a low-barrier proton-transfer network and tuning nanopore polarity. This membrane-mimetic design reduces sulfonate coverage on Pt by 28% and oxygen-transport resistance by 39.4%, delivering a mass-specific power density of 15.8 W mgPt-1 under H2/air conditions, 1.7-fold that of a conventional Pt/C@Nafion cathode. The composite ionomer also demonstrates excellent durability (>120 h at 0.6 V), with a voltage decay rate below 50 μV h-1. This work presents a bioinspired interfacial engineering strategy that reconfigures the three-phase region to mitigate catalyst poisoning and transport losses, offering a viable route to high-performance low-Pt PEMFCs.
中文摘要:质子交换膜燃料电池的性能关键受阴极三相界面控制,其中铂催化剂中毒及质子/氧气传输效率低下严重阻碍了氧还原反应。受生物膜选择性传输的启发,我们开发了一种基于卟啉的有机网络(H-PorBz)作为多功能离子聚合物改性剂,以重构催化剂/离子聚合物/气体三相界面。H-PorBz与Nafion之间通过NH+-H···SO3-相互作用发生原位非共价交联,形成界面层,在抑制磺酸基诱导的铂中毒的同时解耦质子和氧气的传输。光谱学和计算研究表明,H-PorBz通过建立低势垒质子转移网络和调节纳米孔极性,同时提高了质子电导率和氧气传输效率。这种仿膜设计使铂表面的磺酸基覆盖率降低了28%,氧气传输阻力降低了39.4%,在氢气/空气条件下实现了15.8 W mgPt-1的质量比功率密度,是传统Pt/C@Nafion阴极的1.7倍。该复合离子聚合物还表现出优异的耐久性(0.6 V下超过120小时),电压衰减率低于50 μV h-1。这项工作提出了一种仿生界面工程策略,通过重构三相区域来减轻催化剂中毒和传输损失,为高性能低铂质子交换膜燃料电池提供了可行的途径。
Under mild reaction conditions, ammonia synthesis over Ru catalysts is severely constrained by hydrogen poisoning because excessive surface hydrogen blocks the Ru B5 sites required for efficient N2 activation. To overcome this challenge, we design an atomically functionalized support by anchoring isolated Co single atoms at framework sites of K-modified KL zeolite, creating a dual-function support. The Co single atoms serve as hydrogen-accepting sites that continuously remove surface H atoms from Ru via hydrogen spillover, i.e., spatial regulation of surface hydrogen. Moreover, they indirectly strengthen the electron donation from framework K to Ru for N2 activation, without any direct Co → Ru charge transfer, thereby enhancing both the availability and the intrinsic activity of Ru B5 sites for efficient N2 dissociation. This cooperative mechanism is collectively revealed by comprehensive kinetic analyses, operando spectroscopy, isotope-exchange measurements, chemisorption studies, and density functional theory (DFT) calculations. Consequently, Ru/Co1-KL achieves a near-equilibrium ammonia synthesis rate of 65.3 mmol g-1 h-1 at 400 °C and 1 MPa and maintains stable performance for over 1500 h. This work demonstrates that atomic support functionalization can spatially decouple competing adsorption processes at catalytic interfaces, offering an effective strategy for overcoming site-blocking limitations in heterogeneous catalysis.
中文摘要:在温和反应条件下,Ru催化剂上的氨合成因氢中毒而受到严重限制,过量的表面氢会阻碍N2高效活化所需的Ru B5位点。为克服这一挑战,我们将孤立的Co单原子锚定在K修饰的KL沸石骨架位点上,设计了一种原子级功能化的载体,构建了双功能载体。Co单原子作为氢接受位点,通过氢溢流作用持续从Ru表面移除H原子,实现了对表面氢的空间调控。此外,它们间接增强了框架K向Ru的电子供体作用以促进N2活化,且不存在直接的Co至Ru电荷转移,从而提高了Ru B5位点在高效N2解离方面的可用性和本征活性。通过综合动力学分析、原位光谱、同位素交换测量、化学吸附研究和密度泛函理论(DFT)计算揭示了这一协同机制。因此,Ru/Co1-KL在400 °C和1 MPa条件下实现了65.3 mmol g-1 h-1的接近平衡氨合成速率,并在超过1500小时内保持稳定性能。这项工作证明,原子级载体功能化可以在催化界面空间解耦竞争性吸附过程,为克服多相催化中的位点阻塞限制提供了有效策略。
Single-atom alloys (SAAs) are an emerging class of heterogeneous catalysts that maximize atom efficiency by embedding isolated reactive metal atoms within a host metal surface, creating well-defined active sites. Atomic isolation imparts unique catalytic properties, including high selectivity, resistance to poisoning, coking, and sintering, and in some cases the ability to circumvent conventional scaling relationships that limit traditional catalysts. This article focuses on progress in the SAA field since our 2020 review (Chem. Rev.2020, 120, 12044-12088.), while incorporating earlier foundational studies where relevant. We first examine the fundamental principles governing SAA formation, stability, electronic structure, reactivity, and selectivity, drawing on insights from experimental single-crystal model systems and theoretical studies. We then review the application of SAAs in a wide range of industrially important reactions, including hydrogenation, dehydrogenation, selective oxidation, water-gas shift, Fischer-Tropsch synthesis, and dry reforming, among others. Beyond thermal catalysis, SAAs demonstrate great promise in electrocatalysis and plasmon-driven chemistry. Their structurally simple active sites have also enabled the rational design of novel catalysts and promoters that challenge conventional catalytic intuition. Looking ahead, recent advances in computing, including machine-learning potentials, offer the opportunity to explore vast compositional spaces and discover new alloy chemistries for challenging reactions using the SAA concept.
中文摘要:单原子合金(SAAs)是一类新兴的多相催化剂,通过将孤立的活性金属原子嵌入宿主金属表面以最大化原子效率,从而形成定义明确的活性位点。原子隔离赋予了其独特的催化特性,包括高选择性、抗中毒、抗积碳和抗烧结能力,在某些情况下还能克服限制传统催化剂的传统标度关系。本文聚焦于自2020年综述(Chem. Rev. 2020, 120, 12044-12088)以来单原子合金领域的进展,并在适当时纳入早期的基础研究。我们首先基于实验单晶模型系统和理论研究的见解,考察了决定单原子合金形成、稳定性、电子结构、反应性和选择性的基本原理。随后,我们回顾了单原子合金在多种工业重要反应中的应用,包括加氢、脱氢、选择性氧化、水煤气变换、费托合成和干重整等。除热催化外,单原子合金在电催化和等离子体驱动化学中也展现出巨大潜力。其结构简单的活性位点使得设计挑战传统催化直觉的新型催化剂和助剂成为可能。展望未来,计算技术的最新进展,包括机器学习势函数,为探索广阔的成分空间并利用单原子合金概念发现应对挑战性反应的新合金化学提供了机遇。
Acetaminophen (APAP) overdose is a leading cause of drug-induced liver injury, driven by oxidative stress and disruption of mitochondrial and lysosomal homeostasis. While transcription factor EB (TFEB) is a known master regulator of autophagy and antioxidant pathways, the upstream mechanism that triggers its activation during APAP hepatotoxicity remains unclear. Here, we demonstrate that the citrus flavonoid hesperetin orchestrates a PKC-TFEB signaling pathway to simultaneously mitigate oxidative damage and restore organelle function in APAP-induced liver injury. Hesperetin enhanced TFEB nuclear translocation and transcriptional activity, thereby restoring autophagic clearance of APAP-protein adducts and mitochondrial biogenesis, as well as SQSTM1/p62-dependent noncanonical NFE2-like bZIP transcription factor 2 (NFE2L2/NRF2) activation to protect against APAP-induced liver injury. Mechanistically, hesperetin directly targeted and activated protein kinase C (PKC), preventing its degradation and thus leading to TFEB activation. Our study identifies hesperetin as a novel small-molecule activator of a PKC-TFEB pathway, which couples NRF2-dependent redox balance with mitochondrial-lysosomal repair to counteract APAP toxicity. These findings propose a new strategy for treating oxidative-stress-driven liver injury by targeting TFEB-mediated homeostasis.
中文摘要:对乙酰氨基酚过量是导致药物性肝损伤的主要原因,其机制涉及氧化应激以及线粒体和溶酶体稳态的破坏。转录因子EB是已知的自噬和抗氧化通路的主调控因子,但在对乙酰氨基酚肝毒性过程中触发其激活的上游机制尚不清楚。本研究证明,柑橘类黄酮橙皮苷通过协调PKC-TFEB信号通路,同时减轻氧化损伤并恢复细胞器功能,从而改善对乙酰氨基酚诱导的肝损伤。橙皮苷增强了TFEB的核转位和转录活性,进而恢复了对乙酰氨基酚-蛋白加合物的自噬清除、线粒体生物发生,以及依赖SQSTM1/p62的非经典NFE2样bZIP转录因子2激活,从而保护肝脏免受对乙酰氨基酚诱导的损伤。在机制上,橙皮苷直接靶向并激活蛋白激酶C,防止其降解,从而导致TFEB激活。本研究确定橙皮苷为PKC-TFEB通路的一种新型小分子激活剂,该通路将NRF2依赖的红氧平衡与线粒体-溶酶体修复偶联起来以对抗对乙酰氨基酚毒性。这些发现提出了一种通过靶向TFEB介导的稳态来治疗氧化应激驱动型肝损伤的新策略。
7循环支持与休克 (3篇)
临床研究 (2篇)
In acute myocardial infarction complicated by cardiogenic shock (AMI-CS), the myocardium sustains a dual injury: ischemia of the culprit territory and global hypoperfusion from low cardiac output. Whether platelet inhibition at reperfusion affects the microcirculation, the infarct, the noninfarcted myocardium, and ventricular function, and over what time course, has not been examined with serial imaging. The prespecified multimodality imaging substudy of the randomized DAPT-SHOCK-AMI trial (intravenous cangrelor versus crushed oral ticagrelor) addressed this question. Patients at prespecified imaging sites underwent serial echocardiography (208 enrolled; evaluable examinations in 175, 120, and 99 patients in the acute phase, at 1 month, and at 1 year) and cardiac magnetic resonance (CMR; 93 enrolled; 73, 68, and 63); 81 patients (40 and 41) underwent both modalities. Blinded core laboratories analyzed all studies. The primary imaging endpoint was microvascular obstruction (MVO) on acute CMR, evaluable in 60 patients; secondary endpoints were infarct size, native T1 of the global, infarcted, and remote myocardium, left ventricular (LV) ejection fraction (LVEF), global longitudinal strain (GLS), E/e', and left atrial volume, and their changes. Comparisons between the cangrelor and crushed ticagrelor arms used covariate-adjusted logistic or linear regression; the substudy was not separately powered. The odds of acute MVO were lower with cangrelor (adjusted odds ratio 0.27 [95% CI 0.08 to 0.98]; P=0.023). Infarct size did not differ between the arms. At 1 year, native T1 of the remote myocardium was lower with cangrelor (adjusted mean 1114 [95% CI 1057 to 1171] versus 1171 [1115 to 1228] ms; P=0.005). Over 1 year, LVEF increased more with cangrelor on echocardiography (37.9% versus 21.7% of the acute value; adjusted P=0.046) and CMR (15.8% versus 2.1%; P=0.027), with greater improvement in GLS, lower E/e', and less left atrial enlargement; no parameter differed between the arms at 1 month. In AMI-CS, serial multimodality imaging characterized microvascular, tissue-level, and functional injury over 1 year. Cangrelor was associated with less acute MVO, lower remote native T1, and more complete recovery of LV function than crushed ticagrelor, without a difference in infarct size; these hypothesis-generating findings suggest differences in the microcirculation and non-infarcted myocardial injury but do not establish a treatment mechanism.
中文摘要:在急性心肌梗死合并心源性休克中,心肌遭受双重损伤:罪犯血管供血区的缺血以及低心排血量导致的全身低灌注。目前尚未通过系列影像学研究明确再灌注时的血小板抑制是否影响微循环、梗死区、非梗死心肌及心室功能及其时间进程。本研究为随机DAPT-SHOCK-AMI试验(静脉注射坎格瑞洛与嚼服口服替格瑞洛)预先指定的多模态影像亚组研究,旨在探讨该问题。预设影像中心的患者接受了系列超声心动图检查(入组208例;急性期、1个月和1年可评估病例分别为175、120和99例)及心脏磁共振成像(CMR;入组93例;73、68和63例),其中81例患者同时接受了两种模态检查。盲法核心实验室对所有影像资料进行了分析。主要影像终点为急性期CMR上的微血管阻塞,可评估病例60例;次要终点包括梗死面积、全心肌及梗死区和远端心肌的原生T1值、左室射血分数、整体纵向应变、E/e'比值及左房容积及其变化。坎格瑞洛组与嚼服替格瑞洛组的比较采用协变量调整的logistic或线性回归分析,亚组研究未单独设定统计效能。坎格瑞洛组急性微血管阻塞的发生几率较低(调整后比值比0.27 [95%CI 0.08至0.98];P=0.023)。两组间梗死面积无差异。1年时,坎格瑞洛组远端心肌原生T1值较低(调整后均值1114 [95%CI 1057至1171]对比1171 [1115至1228] ms;P=0.005)。在1年随访期间,超声心动图显示坎格瑞洛组左室射血分数增加更多(占急性期基线的37.9%对比21.7%;调整后P=0.046),CMR也显示类似结果(15.8%对比2.1%;P=0.027),且整体纵向应变改善更显著,E/e'比值更低,左房扩大更少;1个月时各组间参数无差异。在急性心肌梗死合并心源性休克中,系列多模态影像在一年的时间内刻画了微循环、组织层面及功能性损伤。坎格瑞洛与较少的急性微血管阻塞、较低的远端原生T1值以及更完全的左室功能恢复相关,而梗死面积无差异;这些产生假说的发现提示微循环和非梗死心肌损伤存在差异,但未能确立治疗机制。
Fulminant myocarditis (FM) is a complex clinical syndrome characterized by acute myocardial inflammation and cardiogenic shock. Evidence on long-term outcomes, mortality risk factors, and targeted treatment options remains limited. This retrospective analysis included consecutive adult patients admitted for FM between January 2012 and November 2022 at 26 European tertiary centres. According to endomyocardial biopsy (EMB) findings, patients were categorized as lymphocytic (LM), eosinophilic (EM), necrotizing eosinophilic (NEM), and giant-cell myocarditis (GCM) for the main analyses. Patients with inconclusive histopathology and those who did not undergo EMB were analysed separately. Primary outcomes were in-hospital and 1-year mortality. Multivariable logistic regression models were employed as generalized linear models to analyse the association of prespecified risk factors with mortality. Estimated associations are reported as odds ratios, generalized marginal effects, and adjusted prediction plots. A total of 271 patients [median age 43 years (interquartile range: 33-55 years), 58% male] were included in the analysis, of whom 146 fulfilled histopathologic criteria of LM (n = 99), EM (n = 18), NEM (n = 3), or GCM (n = 26). In the remaining 125 cases, EMB was inconclusive (n = 48) or not performed (n = 77). While there were no significant differences in cardiac arrest rate, admission Simplified Acute Physiology Score (SAPS) II, ventricular function, initial pH, and liver and kidney function parameters between histopathologic subgroups, the use of immunosuppressive medications and need for organ replacement varied. In the overall population, in-hospital and 1-year mortality were 31% and 34%, respectively. The highest 1-year mortality rate was observed among patients with GCM (LM: 25%, EM: 28%, NEM: 33%, GCM: 54%, P = .04). Patients who survived to discharge had an excellent functional outcome and long-term recovery of ventricular function. In total, 17 patients (6%) received a heart transplant during follow-up. Older age, lower pH, and histopathologic diagnosis of GCM were independently associated with in-hospital and 1-year mortality. In-hospital mortality among patients with FM remains high. Age, pH, and histopathological findings may serve as prognostic markers to identify high-risk patients and to guide treatment strategies. Long-term outcomes are excellent among those who survive to discharge.
中文摘要:暴发性心肌炎是一种以急性心肌炎症和心源性休克为特征的复杂临床综合征。关于长期预后、死亡危险因素及靶向治疗选项的证据仍然有限。这项回顾性分析纳入了2012年1月至2022年11月期间在26个欧洲三级医疗中心收治的连续成年暴发性心肌炎患者。根据心内膜心肌活检结果,主要分析将患者分为淋巴细胞性心肌炎、嗜酸性粒细胞性心肌炎、坏死性嗜酸性粒细胞性心肌炎和巨细胞性心肌炎。组织病理学不明确或未进行心内膜心肌活检的患者被单独分析。主要结局指标为院内死亡率和1年死亡率。采用多变量逻辑回归模型作为广义线性模型,分析预设危险因素与死亡率之间的关联。估计的关联以比值比、广义边际效应和调整预测图的形式报告。分析共纳入271名患者,中位年龄43岁,男性占58%,其中146人符合淋巴细胞性心肌炎、嗜酸性粒细胞性心肌炎、坏死性嗜酸性粒细胞性心肌炎或巨细胞性心肌炎的组织病理学标准。在其余125例中,心内膜心肌活检结果不明确或未进行。尽管不同组织病理学亚组在心搏骤停发生率、入院简化急性生理学评分II、心室功能、初始pH值以及肝肾功能的参数方面无显著差异,但免疫抑制药物的使用和器官替代治疗的需求存在差异。在总体人群中,院内死亡率和1年死亡率分别为31%和34%。巨细胞性心肌炎患者的1年死亡率最高,淋巴细胞性心肌炎为25%,嗜酸性粒细胞性心肌炎为28%,坏死性嗜酸性粒细胞性心肌炎为33%,巨细胞性心肌炎为54%。存活至出院的患者具有良好的功能结局和心室功能的长期恢复。随访期间共有17名患者接受了心脏移植。年龄较大、pH值较低以及巨细胞性心肌炎的组织病理学诊断与院内死亡率和1年死亡率独立相关。暴发性心肌炎患者的院内死亡率仍然较高。年龄、pH值和组织病理学发现可作为预后标志物,用于识别高危患者并指导治疗策略。存活至出院的患者长期预后良好。
基础研究 (1篇)
Cardiogenic shock (CS) is a state of acute circulatory failure resulting from impaired myocardial function and reduced cardiac output, leading to inadequate tissue perfusion and subsequent organ dysfunction. In its early phase, CS is typically accompanied by systemic vasoconstriction as a compensatory response aimed at preserving mean arterial pressure and organ perfusion. However, an increasing body of evidence suggests that a subset of patients develop a mixed shock phenotype, characterized by superimposed vasodilation without evidence of concurrent sepsis, which portends a worse prognosis. Failure of the renin-angiotensin-aldosterone system (RAAS) may be a key driver of pathological vasodilation in CS, analogous to recent observations in septic shock. Specifically, RAAS dysfunction could lead to impaired angiotensin II signalling at the angiotensin II type 1 receptor level due to defective angiotensin II generation, enhanced peptide degradation, and/or receptor unavailability. Recognition of RAAS failure in CS could inform novel therapeutic strategies to restore vascular tone and improve outcomes in patients with mixed cardiogenic-vasodilatory shock.
中文摘要:题目:肾素-血管紧张素-醛固酮系统衰竭驱动心源性休克中的异常血管扩张:一种假说。摘要:心源性休克(CS)是一种由心肌功能受损和心输出量减少引起的急性循环衰竭状态,导致组织灌注不足及随后的器官功能障碍。在早期阶段,CS通常伴有全身性血管收缩作为代偿反应,旨在维持平均动脉压和器官灌注。然而,越来越多的证据表明,部分患者会发展为混合休克表型,其特征是在无脓毒症共存证据的情况下叠加血管扩张,这预示着更差的预后。肾素-血管紧张素-醛固酮系统(RAAS)衰竭可能是CS中病理性血管扩张的关键驱动因素,这与近期在脓毒性休克中的观察结果相似。具体而言,由于血管紧张素II生成缺陷、肽段降解增强和/或受体不可用,RAAS功能障碍可能导致血管紧张素II型1受体水平的血管紧张素II信号传导受损。在CS中识别RAAS衰竭可为恢复血管张力和改善混合心源性-血管扩张性休克患者预后的新型治疗策略提供依据。
8重症医学与其他 (2篇)
临床研究 (2篇)
To define the timing and phenotype of mitochondrial ultrastructural remodeling and electron transport chain (ETC) function in skeletal muscle during early critical illness. Secondary analysis of a prospective observational study with serial muscle biopsies. Adult ICU. Thirty-three mechanically ventilated ICU patients (median age, 49 yr; 27% women) with Sequential Organ Failure Assessment greater than or equal to 9 on three consecutive days; skeletal muscle biopsies of the vastus lateralis muscle at ICU day 5 (n = 29) and day 15 (n = 22). Healthy subjects served as controls. None. Vastus lateralis biopsies were analyzed by electron microscopy with stereology, quantitative real-time PCR (qRT-PCR), Western blotting, and spectrophotometric ETC enzyme assays (reported per tissue weight and normalized to citrate synthase [CS]). Intact mitochondrial profiles were reduced vs. controls (fold change vs. controls: day 5, 0.24 [0.18-0.34]; p = 0.039 and day 15, 0.20 [0.16-0.33]; p = 0.011) and disturbed profiles increased (day 5, 5.62 [3.20-7.17]; p < 0.001 and day 15, 5.20 [3.67-6.36]; p = 0.001), with reduced volume density of intact mitochondria (day 5, 0.33 [0.20-0.49]; p = 0.009 and day 15, 0.32 [0.21-0.50]; p = 0.005). Inner mitochondrial membrane surface-to-volume ratio was reduced at day 5 (0.69 [0.49-0.89]; p = 0.022) and remained unchanged at day 15. Complex III tissue activity was reduced at day 5 (85.6 [22.1-133.3] vs. 151.4 [100.5-205.0]; p = 0.015) and day 15 (50.5 [36.0-69.8]; p = 0.001), remaining reduced after CS normalization (day 5, 0.83 [0.34-1.49]; p = 0.040 and day 15, 0.87 [0.65-0.93]; p = 0.007). Complex IV activity remained reduced before and after CS normalization at both time points (all p < 0.001). CS activity declined by day 15 (56.3 [52.7-65.1] vs. 95.6 [80.1-133.0]; p = 0.001 and day 15 vs. day 5; p = 0.041). qRT-PCR and Western blot supported reduced ETC components and altered biogenesis signaling. Skeletal muscle mitochondrial ultrastructure is altered by ICU day 5 and remains abnormal at day 15, with persistent complex III/IV dysfunction after CS normalization. These findings define an early sustained mitochondrial remodeling phenotype in skeletal muscle during critical illness.
中文摘要:目的:明确危重疾病早期骨骼肌中线粒体超微结构重塑的时间与表型,以及电子传递链(ETC)功能。方法:对一项前瞻性观察性研究进行二次分析,该研究包含连续肌肉活检。地点:成人重症监护室(ICU)。对象:33名机械通气的ICU患者(中位年龄49岁,女性占27%),其序贯器官衰竭评分(SOFA)连续三天大于或等于9分;于ICU第5天(n=29)和第15天(n=22)采集股外侧肌骨骼肌活检样本。健康受试者作为对照。干预:无。结果:通过电子显微镜结合立体定量、定量实时PCR(qRT-PCR)、Western blotting及分光光度法ETC酶活性分析(按组织重量报告并校正至柠檬酸合酶[CS])对股外侧肌活检进行分析。与对照组相比,完整的线粒体轮廓减少(vs. 对照组的倍数变化:第5天为0.24 [0.18-0.34];p=0.039,第15天为0.20 [0.16-0.33];p=0.011),而受损轮廓增加(第5天为5.62 [3.20-7.17];p<0.001,第15天为5.20 [3.67-6.36];p=0.001),完整线粒体的体积密度降低(第5天为0.33 [0.20-0.49];p=0.009,第15天为0.32 [0.21-0.50];p=0.005)。第5天内线粒体内膜表面积与体积之比降低(0.69 [0.49-0.89];p=0.022),至第15天保持无变化。复合物III的组织活性在第5天(85.6 [22.1-133.3] vs. 151.4 [100.5-205.0];p=0.015)和第15天(50.5 [36.0-69.8];p=0.001)均降低,校正CS后仍保持降低状态(第5天为0.83 [0.34-1.49];p=0.040,第15天为0.87 [0.65-0.93];p=0.007)。复合物IV的活性在两个时间点校正前后均保持降低(所有p<0.001)。至第15天CS活性下降(56.3 [52.7-65.1] vs. 95.6 [80.1-133.0];p=0.001,且第15天与第5天相比;p=0.041)。qRT-PCR和Western blot支持ETC成分减少及生物发生信号改变。结论:至ICU第5天骨骼肌线粒体超微结构发生改变,并在第15天保持异常,校正CS后复合物III/IV功能障碍持续存在。这些发现定义了危重疾病期间骨骼肌中早期的持续性线粒体重塑表型。
Post-ICU care often misses patients unable to attend in-person clinic visits. Remote assessments of physical function might increase access to ICU aftercare. We investigated whether patient-reported disability predicts handgrip strength (HGS) and the 2-Minute Walk Test (2MWT) distance with sufficient clinical accuracy. This secondary analysis of the stepped-wedge cluster-randomised Enhanced Recovery after Intensive Care trial included patients from 10 German ICU clusters who completed the WHO Disability Assessment Schedule (WHODAS) 2.0 plus either HGS, the 2MWT, or both, 6 months after ICU discharge. Relationships between WHODAS 2.0, HGS, and 2MWT were analysed using scatter plots, correlation coefficients, linear regressions, and Bland-Altman plots. Predictions of HGS and the 2MWT were compared with the minimal clinically important difference (MCID) for both measures. Of 1463 enrolled patients, 620 were analysed. The median WHODAS 2.0 sum score was 11 (Q1, Q3: 3, 22). The median HGS, expressed as a percentage of the expected value (%exp), was 70.6%exp (Q1, Q3: 54.4, 85.6), and the median 2MWT distance was 73.7%exp (Q1, Q3: 61.5, 85.8). The 2MWT was not completed by 59% of patients. Higher disability was moderately correlated with lower HGS (Spearman %exp: -0.41) and shorter 2MWT distance (Spearman %exp: -0.47). In multivariable regression models, the WHODAS 2.0 sum score predicted HGS in kg (β: -0.27 [95% CI: -0.33 to -0.22]; P<0.001) and 2MWT distance in m (β: -1.94 [95% CI: -2.37 to -1.51]; P<0.001), but the limits of agreement exceeded the MCIDs. With increasing disability, HGS and 2MWT performance declined, although correlations were moderate and uncertainty of predictions exceeded MCIDs of both instruments. Remote WHODAS 2.0 assessments cannot replace in-person physical function testing. NCT03671447.
中文摘要:ICU后护理常遗漏无法亲自参加门诊就诊的患者。远程评估身体功能可能提高ICU后续护理的可及性。我们调查了患者报告的残疾情况是否足以预测握力(HGS)和2分钟步行测试(2MWT)距离的临床准确性。这项对步进楔形集群随机化强化重症后恢复试验的二次分析纳入了来自10个德国ICU集群的患者,这些患者在ICU出院6个月后完成了WHO残疾评估量表(WHODAS)2.0以及HGS、2MWT或两者兼有。使用散点图、相关系数、线性回归和Bland-Altman图分析了WHODAS 2.0、HGS和2MWT之间的关系。将HGS和2MWT的预测值与这两种指标的最小临床重要差异(MCID)进行了比较。在1463名入组患者中,分析了620名患者的数据。WHODAS 2.0总分的中位数为11(Q1, Q3: 3, 22)。HGS占预期值的百分比(%exp)中位数为70.6%exp(Q1, Q3: 54.4, 85.6),2MWT距离的%exp中位数为73.7%exp(Q1, Q3: 61.5, 85.8)。59%的患者未完成2MWT。较高的残疾程度与较低的HGS(Spearman %exp: -0.41)和较短的2MWT距离(Spearman %exp: -0.47)呈中度相关。在多变量回归模型中,WHODAS 2.0总分预测了以kg为单位的HGS(β: -0.27 [95% CI: -0.33 to -0.22]; P<0.001)和以m为单位的2MWT距离(β: -1.94 [95% CI: -2.37 to -1.51]; P<0.001),但一致性界限超过了MCIDs。随着残疾程度增加,HGS和2MWT表现下降,尽管相关性为中度且预测的不确定性超过了两种仪器的MCIDs。远程WHODAS 2.0评估不能替代面对面身体功能测试。NCT03671447.
9ECMO与器官支持 (1篇)
临床研究 (1篇)
Research from a prior era of extracorporeal membrane oxygenation (ECMO) found that higher hospital ECMO volume was associated with higher survival rates, but it did not examine whether distributing ECMO volume across multiple ICUs affected this relationship. Retrospective analysis of the Extracorporeal Life Support Organization (ELSO) registry. ECMO centers contributing to the registry. Adult patients required ECMO support from 2012 to 2023. None. We analyzed adult patients from the ELSO registry (2012-2023), adjusting for hospital factors and case mix using multivariable hierarchical logistic regression. The main outcome was in-hospital mortality. Hospital experience was measured by the annual number of adult ECMO cases and total ECMO hours. Volume-outcome associations were modeled for all centers and by total adult ICUs per center. We included 115,849 adults on ECMO across 495 hospitals. Model estimates showed small decreases in mortality odds with higher annual case counts (odds ratio [OR], 0.98; 95% CI, 0.97-0.99 per 10-case increase) and ECMO hours (OR, 0.99; 95% CI, 0.99-1.00 per 1000 hr increase). Hospitals with one ICU had a median of 10 cases (interquartile interval [IQI], 3-25 cases), while those with four or more ICUs had a median of 50 (IQI, 28-91). Adjusted mortality was higher in centers delivering ECMO across four+ ICUs compared with one ICU (OR, 1.18; 95% CI, 1.06-1.31), the annual case model (OR, 1.16; 95% CI, 1.06-1.26), and the annual ECMO hours model. Higher volume was associated with a reduction in the odds of mortality for hospitals with four+ ICUs compared with those with one ICU (OR, 0.98; 95% CI, 0.96-1.00 per 10 cases and OR, 0.99; 95% CI, 0.99-1.00 per 1000 hr). Higher hospital ECMO volume is associated with reduced mortality. Hospitals with more adult ICUs that perform ECMO may experience higher mortality, which may be explained by increased patient complexity and is offset by the higher center volume. More research is needed to better understand the optimum design of ECMO centers.
中文摘要:既往关于体外膜肺氧合(ECMO)的研究发现,较高的医院ECMO病例量与较高的生存率相关,但未考察将ECMO病例量分布在多个重症监护室(ICU)是否会影响这种关系。本研究对体外生命支持组织(ELSO)登记数据库进行了回顾性分析,纳入2012年至2023年接受ECMO支持的成年患者。研究分析了来自ELSO登记数据库的115,849名成年患者数据,采用多变量分层逻辑回归调整医院因素和病例组合。主要结局为院内死亡率。医院经验通过每年成人ECMO病例数和总ECMO小时数衡量。对全中心及按每个中心的成人ICU总数分组的体积-结果关联进行了建模。结果显示,随着年病例数增加(每增加10例,比值比[OR]为0.98;95%置信区间[CI]为0.97-0.99)和ECMO小时数增加(每增加1000小时,OR为0.99;95% CI为0.99-1.00),死亡率 odds 略有下降。拥有1个ICU的医院中位病例数为10例(四分位距[IQR]为3-25例),而拥有4个或更多ICU的医院中位病例数为50例(IQR为28-91例)。与仅有一个ICU的中心相比,在四个或更多ICU提供ECMO的中心调整后的死亡率更高(OR为1.18;95% CI为1.06-1.31),高于年病例模型(OR为1.16;95% CI为1.06-1.26)和年ECMO小时数模型。与仅有一个ICU的医院相比,较高的病例量与拥有四个或更多ICU的医院的死亡率 odds 降低相关(每增加10例,OR为0.98;95% CI为0.96-1.00,每增加1000小时,OR为0.99;95% CI为0.99-1.00)。较高的医院ECMO病例量与死亡率降低相关。开展ECMO的成人ICU较多的医院可能经历较高的死亡率,这可能是因为患者复杂性增加所致,且被较高的中心病例量所抵消。需要更多研究以更好地理解ECMO中心的最佳设计。
10重症医学与康复 (1篇)
临床研究 (1篇)
To examine physical activity levels in survivors of critical illness across 6 months, and to understand the barriers and facilitators of physical activity. Prospective, longitudinal, convergent mixed-methods study. Functional testing laboratory. Adults admitted to the ICU for at least 72 hours with acute respiratory failure or sepsis. None. Patients wore an accelerometer starting at hospital discharge, at 3- and 6-month follow-up to quantify daily step counts. At 6 months, physical function and patient-reported outcomes were collected in-person, with a subset of participants completing semi-structured interviews. Eighty-two patients were enrolled, with 67 (82%) having physical activity data with median age of 60 years (interquartile range [IQR], 52-66 yr), 54% male, and ICU stay 9.0 days [IQR, 5.8-17.0 d]. The median daily steps were 1358 (IQR, 742-2799) in 50 patients at baseline, 2305 (IQR, 1081-3898) in 54 patients at 3 months, and 2826 (IQR, 1609-4781) in 44 patients at 6 months. Higher comorbidity burden and earlier measurement associated with lower step counts. At 6 months, patients walked a mean of 344 ± 169 meters on the 6-minute walk test and reported being sedentary a median of 300 min/days (150-480 min/d). Eleven participants completed interviews, yielding three themes: 1) "a marathon, not a sprint": the extended ICU recovery trajectory; 2) engagement in physical activity is highly regulated by personal context; 3) value-driven and motivation-informed physical activity decisions. Mixed-methods integration demonstrated that qualitative themes expanded upon quantitative findings to explain nonlinear recovery patterns, contextualizing persistent sedentary behavior, and revealing that motivational and behavioral gaps are not captured by accelerometry. Survivors showed gradual improvement in daily steps over 6 months yet remained below recommended activity levels. Survivorship and attrition biases may lead to overestimation of step counts, further warranting larger studies. Integrating quantitative and qualitative data reveals modifiable contextual factors that may inform the design of pragmatic physical activity interventions.
中文摘要:目的:考察危重症幸存者6个月内的体力活动水平,并了解其体力活动的障碍与促进因素。设计:前瞻性纵向收敛混合方法研究。地点:功能测试实验室。对象:因急性呼吸衰竭或脓毒症入住ICU至少72小时的成人患者。干预措施:无。方法:患者在出院时、3个月和6个月随访期间佩戴加速度计以量化每日步数。在6个月时,面对面收集身体功能和患者报告结局,部分参与者完成半结构化访谈。结果:共纳入82名患者,其中67名(82%)拥有体力活动数据,中位年龄60岁(四分位距[IQR] 52-66岁),男性占54%,ICU住院时间为9.0天(IQR 5.8-17.0天)。基线时50名患者的每日中位步数为1358步(IQR 742-2799),3个月时54名患者为2305步(IQR 1081-3898),6个月时44名患者为2826步(IQR 1609-4781)。合并症负担较高和较早测量与较低的步数相关。在6个月时,患者在6分钟步行试验中平均行走344±169米,并报告每日中位久坐时间为300分钟(150-480分钟)。11名参与者完成访谈,得出三个主题:1)「马拉松而非短跑」:ICU恢复轨迹的长期性;2)体力活动的参与高度受个人背景调节;3)价值驱动且动机影响的体力活动决策。混合方法整合表明,定性主题扩展了定量发现以解释非线性恢复模式,情境化持续久坐行为,并揭示加速度计未能捕捉到动机和行为差距。幸存者在6个月内每日步数逐渐改善,但仍低于推荐的活动水平。幸存者偏差和失访偏倚可能导致步数高估,进一步需要更大规模的研究。整合定性和定量数据揭示了可改变的情境因素,可能为设计务实的体力活动干预措施提供信息。
11创伤与急诊外科 (1篇)
临床研究 (1篇)
Post-traumatic stress disorder affects numerous trauma survivors following emergency department discharge, making this encounter vital for early risk stratification. Yet emergency clinicians face severe time constraints, making existing screening tools impractical. We introduce PREVIA, a clinically-informed large language model ensemble, that predicts post-traumatic stress disorder risk from unstructured patient trauma narratives, collected in response to a routine-care question asked in the emergency department, by extracting early post-traumatic stress symptoms, peri-traumatic symptoms, risk, and protective factors. Within an ongoing longitudinal study, we included N = 145 patients across two New York City level-1 trauma centers within 24 hours of trauma and assessed post-traumatic stress disorder 1-month post-trauma. In this work, PREVIA accurately forecasts post-traumatic stress disorder (AUROC = 78.49% ± 5.75%, sensitivity=95.4% ± 3.99%, precision=46.76% ± 8.66%), performs comparably to an emergency clinician specialized in post-traumatic stress disorder on 30 randomly selected patients (PREVIA: AUROC = 84.39%, sensitivity=100.00%, precision=50.00%; clinician: AUROC = 83.86%, sensitivity=88.89%, precision=50.00%), and generates interpretable explanations without additional clinical burden. These initial findings support PREVIA's potential as a scalable emergency department screener for timely, targeted interventions, and warrant validation in larger, independent cohorts.
中文摘要:创伤后应激障碍影响众多急诊科出院后的创伤幸存者,使此次就诊成为早期风险分层的关键环节。然而,急诊临床医生面临严重的时间限制,导致现有筛查工具难以实施。我们介绍了PREVIA,这是一个临床信息驱动的大型语言模型集成系统,旨在通过提取急诊科常规护理问题回答中非结构化患者创伤叙事中的早期创伤后应激症状、围创伤期症状、风险和保护因素,来预测创伤后应激障碍风险。在一项正在进行的纵向研究中,我们在创伤发生后24小时内纳入了纽约市两家一级创伤中心的145名患者,并在创伤后1个月评估其创伤后应激障碍情况。本研究表明,PREVIA能准确预测创伤后应激障碍(AUROC=78.49%±5.75%,敏感度=95.4%±3.99%,精确度=46.76%±8.66%),在30名随机选择的患者中表现与专门从事创伤后应激障碍的急诊临床医生相当(PREVIA:AUROC=84.39%,敏感度=100.00%,精确度=50.00%;临床医生:AUROC=83.86%,敏感度=88.89%,精确度=50.00%),且在不增加额外临床负担的情况下生成可解释的解释。这些初步结果支持PREVIA作为可扩展的急诊科筛查工具的潜力,用于及时、有针对性的干预,并值得在更大规模的独立队列中进行验证。
12其他 (3篇)
临床研究 (3篇)
To determine the prevalence, risks, and outcomes of obstetric causes of critically ill pregnant women admitted to the ICU. We searched the PubMed, Scopus, Embase, Ovid, and ScienceDirect databases up to May 15, 2026. We included studies reporting primary data on critically ill pregnant and postpartum women (up to 48 d post-delivery) admitted to an ICU, with relevant obstetric risk factors and maternal outcomes. Two reviewers independently performed data extraction and risk-of-bias assessment using the adapted Newcastle-Ottawa Scale. The pooled prevalence was estimated using a random-effects model with 95% CIs. Of the 3,735 total records, 50 studies met the eligibility criteria, encompassing 7,756,232 women receiving obstetric care in tertiary hospitals across 20 countries, with 49,299 ICU admissions. Globally, 1.0% (95% CI, 0.8-1.3%) of pregnant and postpartum women experience critical illness and require admission to an ICU. The frequency varies according to the country's income levels, with the highest in low-income countries (4.1%) and the lowest in high-income countries (0.5%). Notably, 72.3% of ICU admissions were attributed to known obstetric causes, primarily obstetric hemorrhage (23.3%) and hypertension in pregnancy (26.9%). Nearly 33.3% of ICU patients required either respiratory or transfusion support, and the maternal mortality rate among ICU-admitted obstetric women was 8.5%. Nearly one in 100 pregnancies require admission to intensive care due to critical illness, and nearly three-quarters of these admissions were due to direct obstetric causes, with high maternal morbidity and mortality. Obstetric hemorrhage and hypertensive disorders account for the majority of ICU admissions. Strengthening obstetric care in resource-limited settings through the expansion and optimization of intensive care services is essential for improving maternal and neonatal outcomes and reducing preventable morbidity and mortality.
中文摘要:目的:确定入住重症监护室(ICU)的危重孕产妇中产科病因的患病率、风险及结局。方法:检索PubMed、Scopus、Embase、Ovid和ScienceDirect数据库,截止日期为2026年5月15日。纳入报告入住ICU的危重孕妇及产后妇女(分娩后48天内)原始数据的研究,并包含相关产科危险因素及母体结局。两名评审员独立使用改编的新卡斯尔-渥太华量表进行数据提取和偏倚风险评估。采用随机效应模型估算合并患病率及95%置信区间。结果:在3735条记录中,50项研究符合纳入标准,涵盖来自20个国家三级医院接受产科护理的7756232名妇女,其中49299例入住ICU。全球范围内,1.0%(95% CI, 0.8-1.3%)的孕妇及产后妇女经历危重疾病并需入住ICU。患病频率因国家收入水平而异,低收入国家最高(4.1%),高收入国家最低(0.5%)。值得注意的是,72.3%的ICU入院归因于已知的产科病因,主要为产科出血(23.3%)和妊娠期高血压疾病(26.9%)。近33.3%的ICU患者需要呼吸支持或输血支持,入住ICU的产科妇女母体死亡率为8.5%。结论:每100次妊娠中约有1次因危重疾病需入住重症监护室,其中约四分之三的入院由直接产科病因引起,伴有高母体发病率及死亡率。产科出血和高血压疾病占ICU入院的多数。通过扩大和优化重症监护服务以加强资源有限地区的产科护理,对于改善母儿结局及减少可预防的发病率及死亡率至关重要。
This systematic review and meta-analysis determines the incidence of new-onset atrial fibrillation (NOAF) in critically ill patients, risks of post-discharge systemic thromboembolism, anticoagulation therapy, and the proportion diagnosed with AF post-discharge. A search of registered databases (PubMed, Embase, Scopus, and CINAHL) was performed from inception to April 20, 2026. Eligible studies included critically ill patients (≥ 18 yr old) who developed NOAF during admission to general ICUs or high-dependency units. NOAF was defined as AF in patients without prior history of AF. Data were independently extracted from full-text versions of included studies by nonblinded reviewers. A Bayesian meta-analysis was conducted on 54 studies (367,896 patients) with a random-effects model using R (Version 4.3.3). Pooled incidence of NOAF in critically ill patients was 10.6% (95% credible interval [CrI], 8.6-12.9%). Absolute risk of post-discharge systemic thromboembolism was 7.1% (95% CrI, 4.5-11.0%), changing to 6.9% (95% CrI, 4.2-11.6%) after age and sex adjustment. Evidence from six studies reports that critically ill patients with NOAF had 1.94 times (95% CrI, 1.23-3.29) higher relative risk of systemic thromboembolism post-discharge than patients without NOAF, rising to 2.01 (95% CrI, 1.54-2.80) with adjustment. Absolute and relative risk are evaluated with follow-up durations ranging from 1.5 months to 5 years, with variable anticoagulation exposure. Anticoagulation rates were low: 32.9% in-hospital (95% CrI, 14.6-57.9%) and 35.9% post-discharge (95% CrI, 19.7-55.9%). On follow-up, 23.9% (95% CrI, 13.9-38.5%) of critically ill patients with NOAF were subsequently diagnosed with AF. Our review suggests that NOAF during critical illness is associated with significantly increased risk of post-discharge systemic thromboembolism and subsequent AF diagnosis. However, rates of anticoagulation initiation remain low, highlighting the need for improved risk stratification and targeted strategies post-discharge.
中文摘要:本系统综述与荟萃分析旨在确定危重患者中新发房颤(NOAF)的发生率、出院后全身血栓栓塞风险、抗凝治疗情况以及出院后被诊断为房颤的比例。检索了注册数据库(PubMed、Embase、Scopus和CINAHL),时间从建库至2026年4月20日。符合条件的研究包括在入住普通ICU或高依赖病房期间发生NOAF的危重患者(≥18岁)。NOAF定义为无既往房颤病史的患者出现房颤。数据由非盲法评审员独立从纳入研究的全文中提取。使用R软件(版本4.3.3)对54项研究(共367,896名患者)进行了贝叶斯荟萃分析,采用随机效应模型。危重患者NOAF的 pooled 发生率为10.6%(95%可信区间[CrI],8.6-12.9%)。出院后全身血栓栓塞的绝对风险为7.1%(95% CrI,4.5-11.0%),经年龄和性别调整后为6.9%(95% CrI,4.2-11.6%)。六项研究的证据表明,与无NOAF的患者相比,患有NOAF的危重患者出院后发生全身血栓栓塞的相对风险高出1.94倍(95% CrI,1.23-3.29),调整后为2.01倍(95% CrI,1.54-2.80)。绝对风险和相对风险的评估随访时间从1.5个月到5年不等,抗凝治疗暴露情况存在差异。抗凝治疗率较低:院内为32.9%(95% CrI,14.6-57.9%),出院后为35.9%(95% CrI,19.7-55.9%)。随访显示,23.9%(95% CrI,13.9-38.5%)患有NOAF的危重患者随后被诊断为房颤。我们的综述表明,危重疾病期间的NOAF与出院后全身血栓栓塞风险显著增加及后续房颤诊断相关。然而,启动抗凝治疗的比例仍然较低,凸显了改善出院后风险分层和针对性策略的需求。
Alarm fatigue, the desensitization to excessive false alarms, threatens patient safety and staff performance across critical care domains. It is unclear whether alarm fatigue differs between hospital departments. This study compared alarm fatigue among staff in the ICU, cardiac telemetry ward (CTW), and operating room (OR), and, secondarily, identified its independent determinants. Cross-sectional, multicenter survey study. ICUs, a CTW, and ORs. A total of 514 healthcare professionals working in the ICU, CTW, and OR. None. Alarm fatigue was assessed using the Dutch-translated Charité Alarm Fatigue Questionnaire, which includes alarm stress and alarm coping subscales. Participants also rated their self-perceived alarm fatigue on a 1-10 scale and the percentage of perceived false alarms. Telemetry staff reported the highest self-perceived alarm fatigue (B = 0.65; 95% CI, 0.06-1.24; p = 0.032) and perceived false alarms (B = 0.77; 95% CI, 0.23-1.30; p = 0.005), while OR staff reported the lowest (B = -1.01; 95% CI, -1.59 to -0.43; p < 0.001). Second, physicians (B = -0.13; 95% CI, -0.25 to -0.01; p < 0.031) and less experienced staff (< 3 mo; B = -0.34; 95% CI, -0.68 to -0.01; p = 0.046) reported lower alarm fatigue. Alarm fatigue varied significantly across departments and professions, being highest in telemetry staff and lowest among physicians and less experienced personnel. Targeted department-specific interventions and longitudinal research are necessary to mitigate alarm fatigue and enhance patient safety.
中文摘要:警报疲劳即对过多虚假警报的脱敏,威胁着重症监护领域患者安全与人员表现。目前尚不清楚不同医院科室间是否存在警报疲劳差异。本研究比较了重症监护室(ICU)、心脏遥测病房(CTW)和手术室(OR)工作人员的警报疲劳情况,并次要分析了其独立决定因素。这是一项横断面、多中心调查研究。研究对象来自ICU、CTW和OR。共纳入514名在上述科室工作的医疗保健专业人员。无干预措施。使用荷兰语翻译的Charité警报疲劳问卷评估警报疲劳,该问卷包含警报压力和警报应对子量表。参与者还在1-10分量表上对其自我感知的警报疲劳进行评分,并报告了感知到的虚假警报百分比。遥测工作人员报告的自我感知警报疲劳最高(B = 0.65;95% CI, 0.06-1.24;p = 0.032)和感知到的虚假警报最多(B = 0.77;95% CI, 0.23-1.30;p = 0.005),而手术室工作人员报告的最低(B = -1.01;95% CI, -1.59至-0.43;p < 0.001)。其次,医生(B = -0.13;95% CI, -0.25至-0.01;p < 0.031)和经验较少的工作人员(< 3个月;B = -0.34;95% CI, -0.68至-0.01;p = 0.046)报告的警报疲劳较低。不同科室和职业间的警报疲劳存在显著差异,遥测工作人员最高,医生和经验较少人员最低。需要针对特定科室的干预措施和纵向研究来减轻警报疲劳并提高患者安全。